Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Open accessAbstract
Influenza and other respiratory viral infections are the most common type of acute respiratory infection. Viral infections predispose patients to secondary bacterial infections, which often have a more severe clinical course. The mechanisms underlying post-viral bacterial infections are complex, and include multifactorial processes mediated by interactions between viruses, bacteria, and the host immune system. Studies over the past 15 years have demonstrated that unique microbial communities reside on the mucosal surfaces of the gastrointestinal tract and the respiratory tract, which have both direct and indirect effects on host defense against viral infections. In addition, antiviral immune responses induced by acute respiratory infections such as influenza are associated with changes in microbial composition and function ("dysbiosis") in the respiratory and gastrointestinal tract, which in turn may alter subsequent immune function against secondary bacterial infection or alter the dynamics of inter-microbial interactions, thereby enhancing the proliferation of potentially pathogenic bacterial species. In this review, we summarize the literature on the interactions between host microbial communities and host defense, and how influenza, and other acute respiratory viral infections disrupt these interactions, thereby contributing to the pathogenesis of secondary bacterial infections.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes evidence that acute respiratory viral infections—especially influenza—induce dysbiosis in the gut and respiratory tract microbiomes, which in turn alters host immune priming and inter-microbial competition, contributing to secondary bacterial pneumonia. It argues that these microbiome shifts are driven largely by systemic antiviral immune signals rather than direct viral presence at distant sites.
Key findings
- Respiratory viral infection alters the gut microbiome despite no detectable virus in the GI tract: murine influenza models show reduced segmented filamentous bacteria and Lactobacillus/Lactococcus with increased Enterobacteriaceae/Proteobacteria, effects mediated by type I and type II interferons and possibly by reduced caloric intake.
- Viral infection is associated with increased colonization by potential pathogens in the upper respiratory tract: in adults with influenza A, *S. aureus*, *S. pneumoniae*, and *H. influenzae* were present in 12%, 24%, and 32% of infected patients versus 5%, 11%, and 10% of uninfected patients; in children, influenza was associated with a 15-fold increase in nasopharyngeal *S. pneumoniae* titer.
- In a mouse model, intranasal live attenuated influenza vaccine increased nasopharyngeal bacterial density up to 100,000-fold and prolonged *S. pneumoniae* or *S. aureus* carriage 2- to 5-fold.
- Gut microbiome depletion (antibiotics or germ-free status) impairs antiviral and antibacterial immunity—reduced antibody and CD4+/CD8+ T cell responses, defective macrophage IFN responses, decreased phagocytosis and TNF-α—while commensal re-colonization (e.g., *Lactobacillus reuteri*, *Enterococcus faecalis*, *Lactobacillus crispatus*, *Clostridium orbiscindens*) protected against bacterial pneumonia via GM-CSF.
- Inter-microbial competition matters: nasal implantation of a *Corynebacterium* strain eradicated *S. aureus* in 71% of persistent carriers, and *C. accolens* inhibits *S. pneumoniae* growth in vitro via a lipase releasing free fatty acids.
Methods
- Narrative literature review (not a primary study) covering human and animal studies on gut and respiratory tract microbiomes during respiratory viral infection, with a stated focus on the bacterial microbiome because of a paucity of mycobiome and virome studies.
- Synthesizes cross-sectional and longitudinal human studies (16S rRNA sequencing, qPCR, metagenomics, culture-independent pyrosequencing) alongside murine, ferret, and in vitro models, organized by anatomic niche (gut, URT, LRT) and by mechanism (host immune effects, inter-microbial effects, direct viral effects on bacteria).
- No systematic search strategy, inclusion criteria, or quantitative synthesis is reported.
Limitations
- Stated by the paper: protocols for sampling, processing, and bioinformatics of the respiratory microbiome are not standardized; most studies are in animal models, and human studies are small and largely limited to the URT; fungi and viruses (including phages) are largely omitted because 16S rRNA analysis cannot capture them; species-composition studies are insufficient without functional transcriptomic/proteomic characterization; long-term effects of microbiome-modulating therapies (especially antibiotics) are unknown.
- Stated by the paper: cross-sectional human studies are poorly controlled and small relative to confounding variables (age, gender, oral hygiene, smoking, medication, healthcare employment, exposure to children), and are confounded by viral type, sampling timing, infection severity, and antimicrobial use.
- Evident from the text: the central mechanistic claim—that viral-induced microbiome changes cause secondary bacterial pneumonia in humans—is explicitly described as not yet examined ("the effects of these alterations on risk of secondary bacterial pneumonia have not been studied"), and much of the supporting evidence is from murine models under SPF conditions that may not reflect more diverse human or wild-mouse microbiota.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 216 cited sources checked · 0 supported · 0 flagged
- Premisenone given
Antiviral immune responses induced by acute respiratory infections such as influenza are associated with changes in microbial composition and function ("dysbiosis") in the respiratory and gastrointestinal tract.
“antiviral immune responses induced by acute respiratory infections such as influenza are associated with changes in microbial composition and function (“dysbiosis”) in the respiratory and gastrointestinal tract”
Quote in the paperSubstantial claim - Premisenone given
Influenza and other respiratory viral infections predispose patients to secondary bacterial infections.
“Influenza and other respiratory viral infections predispoxsse patients to secondary bacterial super-infections”
Quote in the paperSubstantial claim - Premisenone given
These microbial communities have both direct and indirect effects on host defense against viral infections.
“which have both direct and indirect effects on host defense against viral infections”
Quote in the paperSubstantial claim - Premisecitation
Over half of patients with severe infections in the 1957 H2N2 and 1968 H3N2 pandemics had bacterial complications.
“over half of patients with severe infections in the 1957 H2N2 and 1968 H3N2 pandemics had bacterial complications”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [8] Bisno, 1971, Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic, Am J Med Sci source
Not checked in the free run.
- cites [9] Hers, 1958, Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza, Lancet source
Not checked in the free run.
- cites [10] Oswald, 1958, Pneumonia complicating Asian influenza, Br Med J source
Not checked in the free run.
- Premisenone given
Influenza infection results in significant changes in the gut microbiome, despite the lack of detectable virions in the GI tract.
“influenza infection has been found to result in significant changes in the gut microbiome, despite the lack of detectable virions in the GI tract”
Quote in the paperNot a substantial claim
- Premisecitation
The severity of infection was associated with reductions in dendritic cell migration rate and the number of local T cells.
“The severity of infection was associated with reductions in dendritic cell migration rate and the number of local T cells.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [51] Ichinohe, 2011, Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [52] Abt, 2012, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity source
Not checked in the free run.
- Premisecitation
In flu-infected mice, increased IL-17A levels and numbers of Th17 cells in the small intestine and colon appeared to contribute to intestinal injury.
“flu-infected mice had increased IL-17A levels and numbers of Th17 cells in the small intestine and colon, which appeared to contribute to intestinal injury”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Not checked in the free run.
- Premisecitation
Influenza infection alters intestinal microbiota composition through type II IFN produced by lung-derived T cells recruited to the intestine.
“influenza infection alters intestinal microbiota composition through type II IFN produced by lung-derived T cells recruited to the intestine”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Not checked in the free run.
- Premisecitation
These mice also had higher viral titers in their lungs.
“These mice also had higher viral titers in their lungs”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Ichinohe, 2011, Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
During viral infections, the degree of macrophage response to respiratory viruses depends on the presence of gut microbes.
“During viral infections, the degree of macrophage response to respiratory viruses depends on the presence of gut microbes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Changes in the gut microbiome appear to result not from direct viral effects but from systemic inflammatory signals that travel from the lung and trigger local inflammatory responses in the gut.
“changes in the gut microbiome appear to result not from direct viral effects but from systemic inflammatory signals that travel from the lung and trigger local inflammatory responses in the gut”
Quote in the paperSubstantial claim - Premisecitation
Using animal models of pulmonary infections by influenza and RSV, multiple groups have shown that the gut microbiome is clearly impacted by respiratory viral infections, despite the lack of detectable respiratory virus in the gut.
“Using animal models of pulmonary infections by influenza and respiratory syncytial virus (RSV), multiple groups have shown that the gut microbiome is clearly impacted by respiratory viral infections, despite the lack of detectable respiratory virus in the gut”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Not checked in the free run.
- cites [44] Deriu, 2016, Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons, PLoS Pathog source
Not checked in the free run.
- cites [45] Bartley, 2017, Impact of age, caloric restriction, and influenza infection on mouse gut microbiome: an exploratory study of the role of age-related microbiome changes on influenza responses, Front Immunol source
Not checked in the free run.
- cites [46] Yildiz, 2018, Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis, Microbiome source
Not checked in the free run.
- cites [47] Groves, 2018, Respiratory disease following viral lung infection alters the murine gut microbiota, Front Immunol source
Not checked in the free run.
- Premisecitation
Mice pretreated with an antibiotic cocktail showed increased morbidity and mortality during influenza infection.
“Mice pretreated with an antibiotic cocktail showed increased morbidity and mortality during influenza infection”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [51] Ichinohe, 2011, Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [52] Abt, 2012, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity source
Not checked in the free run.
- Premisecitation
Administration of Lactobacillus reuteri, Enterococcus faecalis, Lactobacillus crispatus, and Clostridium orbiscindens, which are strong stimulators of NOD2, are able to protect against bacterial pneumonia by enhancing GM-CSF production.
“administration of Lactobacillus reuteri, Enterococcus faecalis, Lactobacillus crispatus, and Clostridium orbiscindens, which are strong stimulators of NOD2 (i.e., cytosolic receptor for muramyl dipeptide, which is found in cell walls of certain bacteria), are able to protect against bacterial pneumonia by enhancing GM-CSF production”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Brown, 2017, The microbiota protects against respiratory infection via GM-CSF signaling, Nat Commun source
Not checked in the free run.
- Premisecitation
Activation of antiviral immune responses, including type I and type II IFNs, have been associated with increased susceptibility to secondary bacterial pneumonia.
“activation of antiviral immune responses, including type I and type II IFNs, have been associated with increased susceptibility to secondary bacterial pneumonia”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Sun, 2008, Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection, Nat Med source
Not checked in the free run.
- cites [65] Shahangian, 2009, Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice, J Clin Invest source
Not checked in the free run.
- Interpretationcitation
These effects might be mediated in part by decreased Nod1 sensing of meso-DAP-containing peptidoglycan found in gut microbiota, which previously was shown to be essential for priming innate immune responses to S. pneumoniae.
“These effects might be mediated in part by decreased Nod1 sensing of meso-DAP (diaminopimelic acid)-containing peptidoglycan found in gut microbiota, which previously was shown to be essential for priming innate immune responses to S. pneumoniae”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Clarke, 2010, Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity, Nat Med source
Not checked in the free run.
- Premisecitation
Other Lactobacillus strains are known to enhance TNF-α and IFN-γ production by nasal lymphocytes upon influenza infection.
“Other Lactobacillus strains are known to enhance TNF-α and IFN-γ production by nasal lymphocytes upon influenza infection”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Hori, 2002, Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota, Clin Diagn Lab Immunol source
Not checked in the free run.
- Premisecitation
Clostridium orbiscindens produces desaminotyrosine (DAT) from metabolism of flavonoids and amino acids.
“Clostridium orbiscindens, a member of the human gut microbiome, has been found to produce desaminotyrosine (DAT) from metabolism of flavonoids and amino acids.”
Quote in the paperSubstantial claim - Interpretationreasoning
Antibiotic-induced disruptions in the normal gut microbial community alter multiple aspects of normal host defense against acute respiratory pathogens.
“antibiotic-induced disruptions in the normal gut microbial community alter multiple aspects of normal host defense against acute respiratory pathogens”
Quote in the paperSubstantial claim - Premisecitation
Bacterial colonization of the URT is generally considered as the first step in the development of invasive bacterial infections, including secondary bacterial infections following respiratory viral infection.
“bacterial colonization of the URT is generally considered as the first step in the development of invasive bacterial infections (83, 84), including secondary bacterial infections following respiratory viral infection”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Higher pneumococcal colonization density has been linked to respiratory virus co-infection and invasive pneumococcal pneumonia, after adjusting for age and sex.
“Higher pneumococcal colonization density has been linked to respiratory virus co-infection and invasive pneumococcal pneumonia, after adjusting for age and sex”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Wolter, 2014, High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia, J Infect Dis source
Not checked in the free run.
- Premisecitation
In experimental in vitro models, viral infections increase the colonization rates of various bacteria in the URT, including S. pneumoniae and H. influenzae.
“In experimental in vitro models, viral infections increase the colonization rates of various bacteria in the URT (90–95), including S. pneumoniae and H. influenzae (86–88).”
Quote in the paperSubstantial claim0 of 9 sources checked- cites [90] Hirano, 1999, Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization, Otolaryngol Head Neck Surg source
Not checked in the free run.
- cites [91] McCullers, 2010, Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets, J Infect Dis source
Not checked in the free run.
- cites [92] Wadowsky, 1995, Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects, Infect Immun source
Not checked in the free run.
- cites [93] Wren, 2014, Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation, Infect Immun source
Not checked in the free run.
- cites [94] Nakamura, 2011, Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice, J Clin Invest source
Not checked in the free run.
- cites [95] Diavatopoulos, 2010, Influenza A virus facilitates Streptococcus pneumoniae transmission and disease, FASEB J source
Not checked in the free run.
- cites [86] Ishizuka, 2003, Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells, J Infect Dis source
Not checked in the free run.
- cites [87] Avadhanula, 2006, Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner, J Virol source
Not checked in the free run.
- cites [88] Wang, 2009, Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously, Laryngoscope source
Not checked in the free run.
- Premisecitation
Impaired airway clearance due to intrinsic or extrinsic factors leads to the proliferation of bacterial species that can exploit this growth opportunity.
“Impaired airway clearance due to intrinsic or extrinsic factors leads to the proliferation of bacterial species that can exploit this growth opportunity”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Rogers, 2013, Interpreting infective microbiota: the importance of an ecological perspective, Trends Microbiol source
Not checked in the free run.
- Interpretationcitation
One possible mechanism by which influenza and other viral infections might predispose infected hosts to secondary bacterial pneumonia is by altering the microbial composition of the upper respiratory tract, fostering enhanced growth of pathogens, and facilitating the subsequent entry of large bacterial loads into the LRT.
“One possible mechanism by which influenza and other viral infections might predispose infected hosts to secondary bacterial pneumonia is by altering the microbial composition of the upper respiratory tract, fostering enhanced growth of pathogens, and facilitating the subsequent entry of large bacterial loads into the LRT”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Wolter, 2014, High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia, J Infect Dis source
Not checked in the free run.
- Premisecitation
In healthy individuals, the microbial community richness is lower in the LRT than that in the URT.
“In healthy individuals, the microbial community richness (i.e., the total number of bacterial taxa) is lower in the LRT than that in the URT”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [70] Charlson, 2011, Topographical continuity of bacterial populations in the healthy human respiratory tract, Am J Respir Crit Care Med source
Not checked in the free run.
- cites [74] Dickson, 2017, Bacterial topography of the healthy human lower respiratory tract, MBio source
Not checked in the free run.
- cites [75] Abreu, 2012, Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis, Sci Transl Med source
Not checked in the free run.
- cites [76] Bassis, 2015, Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals, MBio source
Not checked in the free run.
- Premisecitation
Given the effects of viruses on enhancing bacterial adherence to the epithelium, multiple studies of human subjects as well as in animal models have shown that viral infections are associated with increased colonization by potentially pathogenic bacteria.
“Given the effects of viruses on enhancing bacterial adherence to the epithelium (86–88), it is perhaps not surprising that multiple studies of human subjects as well as in animal models have shown that viral infections are associated with increased colonization by potentially pathogenic bacteria”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] Ishizuka, 2003, Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells, J Infect Dis source
Not checked in the free run.
- cites [87] Avadhanula, 2006, Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner, J Virol source
Not checked in the free run.
- cites [88] Wang, 2009, Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously, Laryngoscope source
Not checked in the free run.
- Premisecitation
In children, influenza is associated with a 15-fold increase in nasopharyngeal titer of S. pneumoniae.
“In children, influenza is associated with a 15-fold increase in nasopharyngeal titer of S. pneumoniae”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] Vu, 2011, Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children, Pediatr Infect Dis J source
Not checked in the free run.
- Premisecitation
Animal models have confirmed that viral infection, particularly influenza, increases bacterial colonization rates in the URT, enhancing the risk of secondary bacterial infections.
“Animal models have similarly confirmed that viral infection, particularly influenza, increases bacterial colonization rates in the URT, enhancing the risk of secondary bacterial infections”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [97] Takase, 1999, Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus, Microbiol Immunol source
Not checked in the free run.
- cites [98] Tong, 2000, Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla, Ann Otol Rhinol Laryngol source
Not checked in the free run.
- cites [99] Peltola, 2006, Bacterial sinusitis and otitis media following influenza virus infection in ferrets, Infect Immun source
Not checked in the free run.
- Premisecitation
A comparative analysis using qPCR to detect specific bacteria in adult patients with or without influenza A infection showed that Staphylococcus aureus, S. pneumoniae, and H. influenzae were present in 12, 24, and 32% of infected patients, respectively as compared to 5, 11, and 10% of uninfected patients.
“A comparative analysis using qPCR to detect specific bacteria in adult patients with or without influenza A infection showed that Staphylococcus aureus, S. pneumoniae, and H. influenzae were present in 12, 24, and 32% of infected patients, respectively as compared to 5, 11, and 10% of uninfected patients”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Safaeyan, 2015, Quantitative detection of Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in patients with new influenza A (H1N1)/2009 and influenza A/2010 virus infection, GMS Hyg Infect Control source
Not checked in the free run.
- Premisecitation
An examination of the oropharyngeal microbiome of pneumonia patients with and without 2009 influenza A H1N1 pandemic viral infection showed that Firmicutes (which include Staphylococcus and Streptococcus spp.) and Proteobacteria (mainly Pseudomonas amygdali, P. fluorescens, Pseudomonas sp. UK4, Acinetobacter baumanii and A. junii) were significantly enriched in patients with influenza.
“An examination of the oropharyngeal microbiome of pneumonia patients with and without 2009 influenza A H1N1 pandemic viral infection showed that Firmicutes (which include Staphylococcus and Streptococcus spp.) and Proteobacteria (mainly Pseudomonas amygdali, P. fluorescens, Pseudomonas sp. UK4, Acinetobacter baumanii and A. junii)—were significantly enriched in patients with influenza (108).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
Not checked in the free run.
- Premisecitation
A recent study of subjects with and without respiratory viral infections demonstrated lower overall bacterial reads from nasopharyngeal samples in virally-infected subjects compared with uninfected controls.
“A recent study of subjects with and without respiratory viral infections demonstrated lower overall bacterial reads from nasopharyngeal samples in virally-infected subjects compared with uninfected controls”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Edouard, 2018, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
- Interpretationreasoning
The relationship between acute viral infections and bacterial colonization appears to be bidirectional.
“The relationship between acute viral infections and bacterial colonization appears to be bidirectional.”
Quote in the paperNot a substantial claim - Premisecitation
A French study of children admitted to the hospital with influenza revealed increased diversity of the nasopharyngeal microflora with increased influenza severity.
“A French study of children admitted to the hospital with influenza revealed increased diversity of the nasopharyngeal microflora with increased influenza severity (105).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Langevin, 2017, Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study, J Gen Virol source
Not checked in the free run.
- Premisecitation
A French study of nasopharyngeal samples and a South Korean study of oropharyngeal samples from patients with acute respiratory viral infections both displayed decreases in diversity indices during viral infections compared to healthy controls.
“Conversely, a French study of nasopharyngeal samples and a South Korean study of oropharyngeal samples from patients with acute respiratory viral infections both displayed decreases in diversity indices during viral infections compared to healthy controls (71, 100).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Not checked in the free run.
- cites [100] Edouard, 2018, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
- Premisecitation
Colonization of the URT with S. aureus drastically reduced influenza-induced acute lung injury and mortality in mice by recruiting a C-C chemokine receptor type 2+ CD11b+ monocyte subset to the lungs and inducing an M2 macrophage phenotype.
“colonization of the URT with S. aureus drastically reduced influenza-induced acute lung injury and mortality in mice by recruiting a C-C chemokine receptor type 2+ cluster of differentiation (CD)11b+ monocyte subset to the lungs and inducing an M2 macrophage phenotype”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] Wang, 2013, Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages, Nat Commun source
Not checked in the free run.
- Premisecitation
A recent metagenomics-based study in France reported enrichment of S. aureus, S. pneumoniae, H. influenzae, Moraxella catarrhalis and Klebsiella pneumoniae in nasopharyngeal samples of subjects with confirmed respiratory viral infections compared to healthy controls.
“A recent metagenomics-based study in France reported enrichment of S. aureus, S. pneumoniae, H. influenzae, Moraxella catarrhalis and Klebsiella pneumoniae in nasopharyngeal samples of subjects with confirmed respiratory viral infections compared to healthy controls (100).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Edouard, 2018, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
- Premisecitation
The presence of a nasopharyngeal commensal protected mice against RSV-induced airway hyperresponsiveness.
“The presence of a nasopharyngeal commensal protected mice against RSV-induced airway hyperresponsiveness.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Ni, 2012, Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection, PLoS ONE source
Not checked in the free run.
- Interpretationreasoning
Results from microbiome analyses have not demonstrated consistent changes in diversity when comparing virally infected subjects with healthy controls.
“Results from microbiome analyses have not demonstrated consistent changes in diversity when comparing virally infected subjects with healthy controls.”
Quote in the paperNot a substantial claim - Premisecitation
In some studies, increased bacterial diversity appeared to be associated with influenza severity.
“In some studies, increased bacterial diversity appeared to be associated with influenza severity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Langevin, 2017, Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study, J Gen Virol source
Not checked in the free run.
- Premisecitation
Viral replication in the respiratory tract can be enhanced by exposure to S. pneumoniae.
“Viral replication in the respiratory tract can be enhanced by exposure to S. pneumoniae”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Verkaik, 2011, Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection, Clin Microbiol Infect source
Not checked in the free run.
- Premisecitation
Patients harboring S. pneumoniae are more likely to experience subsequent acute respiratory illness episodes than those without colonization.
“Patients harboring S. pneumoniae are more likely to experience subsequent acute respiratory illness episodes than those without colonization”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] DE, 2016, Co-colonization by Streptococcus pneumoniae and Staphylococcus aureus in the throat during acute respiratory illnesses, Epidemiol Infect source
Not checked in the free run.
- Premisecitation
Longitudinal studies conducted in healthy volunteers who underwent experimental self-innoculation with rhinovirus failed to demonstrate significant changes in diversity of the URT microbiome.
“Longitudinal studies conducted in healthy volunteers who underwent experimental self-innoculation with rhinovirus also failed to demonstrate significant changes in diversity of the URT microbiome”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- Premisecitation
Administration of LAIV vaccine to healthy adults led to increases in diversity measures following viral challenge.
“while administration of LAIV vaccine to healthy adults led to increases in diversity measures following viral challenge (73, 107).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- Premisecitation
A 16s rRNA sequencing-based study conducted in infants with acute RSV or hRV respiratory infections reported that infants with RSV had significantly higher abundance of Staphylococcus spp. compared to hRV-infected infants.
“A 16s rRNA sequencing-based study conducted in infants with acute RSV or hRV respiratory infections reported that infants with RSV had significantly higher abundance of Staphylococcus spp. compared to hRV-infected infants (113).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] Rosas-Salazar, 2016, Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy, J Infect Dis source
Not checked in the free run.
- Premisecitation
Another study examining the presence of 20 respiratory viruses by PCR panel and prevalence of bacterial carriage in the nasopharynx of children found a strong positive association between S. aureus colonization and influenza virus.
“Another study examining the presence of 20 respiratory viruses by PCR panel and prevalence of bacterial carriage in the nasopharynx of children found a strong positive association between S. aureus colonization and influenza virus (112).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] van, 2012, Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria, PLoS ONE source
Not checked in the free run.
- Premisecitation
H. influenzae was positively associated with hRV and RSV.
“H. influenzae was positively associated with hRV and RSV;”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] van, 2012, Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria, PLoS ONE source
Not checked in the free run.
- Premisecitation
In 87.5% of patients, operational taxonomic units (OTUs) in patients varied significantly between time points.
“Moreover, in 87.5% of patients, operational taxonomic units (OTUs) in patients varied significantly between time points (115).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Pérez-Losada, 2017, Nasopharyngeal microbiome diversity changes over time in children with asthma, PLoS ONE source
Not checked in the free run.
- Premisecitation
S. pneumoniae colonization was positively associated with the presence of hRV and enteroviruses.
“Moreover, S. pneumoniae colonization was positively associated with the presence of hRV and enteroviruses;”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] van, 2012, Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria, PLoS ONE source
Not checked in the free run.
- Premisecitation
Another group found that Moraxella and Enterobacter spp. (which are classified as Proteobacteria) were the most highly represented bacteria in nasopharyngeal samples obtained from patients with pandemic H1N1 influenza.
“These findings are supported by another group who found that Moraxella and Enterobacter spp. (which are classified as Proteobacteria) were the most highly represented bacteria in nasopharyngeal samples obtained from patients with pandemic H1N1 influenza (110).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Greninger, 2010, A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America, PLoS ONE source
Not checked in the free run.
- Premisecitation
Another study of patients with 2009 pandemic H1N1 influenza infection revealed that the predominant phyla of the upper respiratory tract (nasal and nasopharyngeal samples) in patients harboring pandemic H1N1 were Actinobacteria, Firmicutes, and Proteobacteria although normal controls were not included.
“Another study of patients with 2009 pandemic H1N1 influenza infection revealed that the predominant phyla of the upper respiratory tract (nasal and nasopharyngeal samples) in patients harboring pandemic H1N1 were Actinobacteria, Firmicutes, and Proteobacteria although normal controls were not included;”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] Chaban, 2013, Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza, PLoS ONE source
Not checked in the free run.
- Premisecitation
M. catarrhalis colonization was positively associated with coronaviruses and adenoviruses.
“and M. catarrhalis colonization was positively associated with coronaviruses and adenoviruses.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] van, 2012, Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria, PLoS ONE source
Not checked in the free run.
- Interpretationreasoning
This may underlie the highly variable and sometimes discrepant observations from microbiome studies in patients with viral infections.
“This may underlie the highly variable and sometimes discrepant observations from microbiome studies in patients with viral infections.”
Quote in the paperSubstantial claim - Premisecitation
Another analysis of two nasopharyngeal washes collected 5.5-6.5 months apart from 40 children and adolescents with asthma showed no significant differences in nasopharyngeal microbiome diversity across seasons.
“However, another analysis of two nasopharyngeal washes collected 5.5–6.5 months apart from 40 children and adolescents with asthma showed no significant differences in nasopharyngeal microbiome diversity across seasons”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Pérez-Losada, 2017, Nasopharyngeal microbiome diversity changes over time in children with asthma, PLoS ONE source
Not checked in the free run.
- Premisecitation
By 60 days, abundance of these bacteria had returned to baseline.
“By 60 days, abundance of these bacteria had returned to baseline.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Hofstra, 2015, Changes in microbiota during experimental human Rhinovirus infection, BMC Infect Dis source
Not checked in the free run.
- Study design and conductnone given
The number of subjects were small in both studies, limiting the power to detect changes over time.
“However, the number of subjects were small in both studies, limiting the power to detect changes over time.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
- cites [119] Hofstra, 2015, Changes in microbiota during experimental human Rhinovirus infection, BMC Infect Dis source
Not checked in the free run.
- Premisecitation
A longitudinal study of healthy subjects found a significant association between the presence of Lactobacillus helveticus, Prevotella melaninogenica, Streptococcus infantis, Veillonella dispar, and Bacteroides ovatus and influenza-specific H1 and H3 IgA antibody response.
“A longitudinal study of healthy subjects found a significant association between the presence of Lactobacillus helveticus, Prevotella melaninogenica, Streptococcus infantis, Veillonella dispar, and Bacteroides ovatus and influenza-specific H1 and H3 IgA antibody response (122).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] Salk, 2016, Taxa of the nasal microbiome are associated with influenza-specific IgA response to live attenuated influenza vaccine, PLoS ONE source
Not checked in the free run.
- Premisecitation
These changes were not observed in subjects given saline nasal spray.
“These changes were not observed in subjects given saline nasal spray.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- Premisecitation
Mean density of all bacterial species was significantly higher at each visit when a virus was detected.
“Mean density of all bacterial species was significantly higher at each visit when a virus was detected.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] DeMuri, 2018, Dynamics of bacterial colonization with streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection, Clin Infect Dis source
Not checked in the free run.
- Premisecitation
Nasopharyngeal microbiota composition has been shown to be altered by influenza vaccination.
“Nasopharyngeal microbiota composition has been shown to be altered by influenza vaccination (Figure 3).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [120] Thors, 2016, The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds. a randomized controlled trial, Am J Respir Crit Care Med source
Not checked in the free run.
- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- cites [121] Mina, 2014, Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice, MBio source
Not checked in the free run.
- Premisecitation
One clinical investigation assessed the presence and density of S. pneumoniae, H. influenzae, and M. catarrhalis in the nasopharynx of children during URT infection and in the healthy state, and reported that the proportion of children colonized with these bacteria was higher during infection than during asymptomatic surveillance visits.
“One clinical investigation assessed the presence and density of S. pneumoniae, H. influenzae, and M. catarrhalis in the nasopharynx of children during URT infection and in the healthy state, and reported that the proportion of children colonized with these bacteria was higher during infection than during asymptomatic surveillance visits.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] DeMuri, 2018, Dynamics of bacterial colonization with streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection, Clin Infect Dis source
Not checked in the free run.
- Premisecitation
No differences in Staphylococcus were observed.
“No differences in Staphylococcus were observed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
- Premisecitation
Experimental inoculation of hRV into the URT (nares) resulted in no significant changes in total read counts or of the main phyla (e.g., Actinobacteria, Firmicutes, and Proteobacteria) over time in nasopharyngeal samples or throat swabs.
“These studies reported no significant changes in total read counts or of the main phyla (e.g., Actinobacteria, Firmicutes, and Proteobacteria) over time in nasopharyngeal samples (73) or throat swabs (119).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
- cites [119] Hofstra, 2015, Changes in microbiota during experimental human Rhinovirus infection, BMC Infect Dis source
Not checked in the free run.
- Premisecitation
The most frequently detected pathogens were methicillin-resistant Staphylococcus aureus (MRSA), M. catarrhalis, and coronavirus.
“The most frequently detected pathogens were methicillin-resistant Staphylococcus aureus (MRSA), M. catarrhalis, and coronavirus.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Hassoun, 2015, Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study, Am J Infect Control source
Not checked in the free run.
- Premisecitation
Data from a mouse model of influenza infection indicate that flu infection has only a modest effect on bacterial counts, diversity and composition of the lung microbiome.
“Data from a mouse model of influenza infection seem to indicate that flu infection has only a modest effect on bacterial counts, diversity and composition of the lung microbiome (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Yildiz, 2018, Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis, Microbiome source
Not checked in the free run.
- Premisecitation
This effect was not observed in uninfected animals.
“However, this effect was not observed in uninfected animals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Takase, 1999, Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus, Microbiol Immunol source
Not checked in the free run.
- Interpretationcitation
Pneumococcal infection may sequentially develop from the URT to the LRT in influenza virus-infected subjects.
“This suggests that pneumococcal infection may sequentially develop from the URT to the LRT in influenza virus-infected subjects (97).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Takase, 1999, Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus, Microbiol Immunol source
Not checked in the free run.
- Premisecitation
In a mouse model of S. aureus nasal colonization, the absence of type I IFN receptor was associated with decreased persistence of bacteria.
“In a mouse model of S. aureus nasal colonization, the absence of type I IFN receptor was associated with decreased persistence of bacteria (107).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- Interpretationcitation
It is possible that some individuals with influenza infection might develop changes in their lung microbiome as a result of changes in their URT microbial communities.
“Thus, it is possible that some individuals with influenza infection might develop changes in their lung microbiome as a result of changes in their URT microbial communities.”
Quote in the paperNot a substantial claim - Premisecitation
Type III IFN, which is also induced during influenza infections, led to changes in the nasal microbiome, including increased numbers of culturable bacteria.
“Type III IFN, which is also induced during influenza infections, led to changes in the nasal microbiome, including increased numbers of culturable bacteria.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [123] Planet, 2016, Lambda interferon restructures the nasal microbiome and increases susceptibility to staphylococcus aureus superinfection, MBio source
Not checked in the free run.
- Interpretationreasoning
It is remarkable that a relatively mild viral stimulus such as flu vaccine can lead to detectable changes in the URT microbiome.
“Thus, it is remarkable that a relatively mild viral stimulus such as flu vaccine can lead to detectable changes in the URT microbiome.”
Quote in the paperNot a substantial claim - Premisecitation
S. pneumoniae intranasally inoculated into mice pre-infected with influenza virus first colonized the nose, followed by the trachea and lungs several days later with purulent inflammation.
“S. pneumoniae intranasally inoculated into mice pre-infected with influenza virus first colonized the nose, followed by the trachea and lungs several days later with purulent inflammation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Takase, 1999, Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus, Microbiol Immunol source
Not checked in the free run.
- Premisecitation
The growth of bacteria seemed to arise from the existing community.
“The researchers observed that the growth of bacteria seemed to arise from the existing community.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] Molyneaux, 2013, Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med source
Not checked in the free run.
- Interpretationcitation
Animal studies have suggested that antiviral immune activation contributes to changes in the URT microbiome and facilitate colonization by potential pathogens, such as S. aureus.
“Although the data are still preliminary, animal studies have suggested that antiviral immune activation contributes to changes in the URT microbiome and facilitate colonization by potential pathogens, such as S. aureus.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
- cites [123] Planet, 2016, Lambda interferon restructures the nasal microbiome and increases susceptibility to staphylococcus aureus superinfection, MBio source
Not checked in the free run.
- Premisecitation
An early study in Japan reported that introducing a Corynebacterium strain into the nares of healthy adult hospital workers who were persistent carriers of S. aureus resulted in successful eradication in 71% of subjects.
“An early study in Japan reported on the effects of introducing a Corynebacterium strain into the nares of healthy adult hospital workers who were persistent carriers of S. aureus, with successful eradication in 71% of subjects (137).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] Uehara, 2000, Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp, J Hosp Infect source
Not checked in the free run.
- Premisecitation
Prior viral infections dysregulate both alveolar macrophages and neutrophils, thereby inhibiting bactericidal activity.
“Prior viral infections dysregulate both alveolar macrophages (64, 131–136) and neutrophils (65, 128, 129), thereby inhibiting bactericidal activity.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [64] Sun, 2008, Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection, Nat Med source
Not checked in the free run.
- cites [131] Astry, 1984, Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis, J Virol source
Not checked in the free run.
- cites [132] Franke-Ullmann, 1995, Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro, J Immunol source
Not checked in the free run.
- cites [133] Ghoneim, 2013, Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections, J Immunol source
Not checked in the free run.
- cites [134] Jakab, 1982, Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia, Am Rev Respir Dis source
Not checked in the free run.
- cites [135] Kleinerman, 1976, Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice, Am J Pathol
Not checked in the free run.
- cites [136] Nickerson, 1990, Pulmonary antibacterial defenses during mild and severe influenza virus infection, Infect Immun source
Not checked in the free run.
- cites [65] Shahangian, 2009, Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice, J Clin Invest source
Not checked in the free run.
- Rests on an assumption: Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.
- Premisecitation
S. epidermidis and Propionibacterium acnes abundance in the nares has been shown to be negatively associated with S. aureus carriage.
“For example, S. epidermidis and Propionibacterium acnes abundance in the nares has been shown to be negatively associated with S. aureus carriage (67).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Frank, 2010, The human nasal microbiota and Staphylococcus aureus carriage, PLoS ONE source
Not checked in the free run.
- Interpretationreasoning
With multiple aspects of pulmonary host defense impaired, a subset of influenza infected patients may develop secondary bacterial pneumonia as a result of being unable to clear aspirated pathobionts from the URT.
“Thus, with multiple aspects of pulmonary host defense impaired, it would not be entirely surprising if a subset of influenza infected patients developed secondary bacterial pneumonia as a result of being unable to clear aspirated pathobionts from the URT.”
Quote in the paperSubstantial claim- Rests on an assumption: Bacterial pneumonia frequently arises as a result of aspirated bacterial pathogens.
- Rests on an assumption: Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.
- Premisecitation
A metagenomic analysis showed that pH1N1-associated airway microbiotas were enriched in genes associated with cell motility, transcriptional regulation, metabolism, and response to chemotaxis compared to the same bacteria in non-infected patients.
“A metagenomic analysis showed that pH1N1-associated airway microbiotas were enriched in genes associated with cell motility, transcriptional regulation, metabolism, and response to chemotaxis compared to the same bacteria in non-infected patients (108).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
Not checked in the free run.
- Premisecitation
S. epidermidis implantation did not have an effect on S. aureus eradication.
“In comparison, S. epidermidis implantation did not have an effect.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] Uehara, 2000, Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp, J Hosp Infect source
Not checked in the free run.
- Premisecitation
Respiratory viral infections impair innate immune responses against bacteria.
“Third, respiratory viral infections impair innate immune responses against bacteria (128–130).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [128] Abramson, 1982, Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus, Infect Immun source
Not checked in the free run.
- cites [129] Didierlaurent, 2008, Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection, J Exp Med source
Not checked in the free run.
- cites [130] McNamee, 2006, Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection, Infect Immun source
Not checked in the free run.
- Interpretationreasoning
Direct effects of the infecting virus on bacteria that comprise the microbiome may facilitate the transition from pathobiont to pathogen.
“Finally, direct effects of the infecting virus on bacteria that comprise the microbiome may facilitate the transition from pathobiont to pathogen.”
Quote in the paperSubstantial claim - Premisenone given
Large-scale sequencing-based microbiome analyses have revealed who is not present during disease.
“In addition to enabling us to determine what is present during states of health, large-scale sequencing-based microbiome analyses have also revealed who is not present during disease.”
Quote in the paperSubstantial claim - Interpretationnone given
Activation of influenza-induced antiviral interferon pathways can lead to inadequate innate immune cell responses during host defense against secondary bacterial infections, resulting in the proliferation of potentially pathogenic bacterial species.
“Activation of influenza-induced antiviral interferon pathways can lead to inadequate innate immune cell responses during host defense against secondary bacterial infections, resulting in the proliferation of potentially pathogenic bacterial species.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Direct effects of viruses on bacterial transcriptional patterns might be a mechanism by which colonizing bacteria acquire invasive potential, thereby leading to bacterial superinfections.
“Thus, direct effects of viruses on bacterial transcriptional patterns might be a mechanism by which colonizing bacteria acquire invasive potential, thereby leading to bacterial superinfections.”
Quote in the paperSubstantial claim - Premisecitation
Influenza affects the S. pneumoniae transcriptome in terms of downregulating expression of genes associated with the colonizer state and upregulations of bacteriocins.
“Influenza has been shown to affect the S. pneumoniae transcriptome in terms of downregulating expression of genes associated with the colonizer state and upregulations of bacteriocins (142).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Pettigrew, 2014, Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection, Infect Immun source
Not checked in the free run.
- Interpretationreasoning
Recent microbiome literature provides additional insights into the pathogenesis of dysregulated immune responses following acute viral infections, that may promote the development of secondary bacterial pneumonias.
“Although the picture is incomplete, recent microbiome literature provides additional insights into the pathogenesis of dysregulated immune responses following acute viral infections, that may promote the development of secondary bacterial pneumonias (Figure 4).”
Quote in the paperSubstantial claim - Interpretationnone given
Respiratory viral infections can initiate a cascade of host immune responses that alter microbial growth conditions in the URT, LRT, and the gut.
“Respiratory viral infections can initiate a cascade of host immune responses that alter microbial growth conditions in the URT, LRT, and the gut (Supplemental Table 1).”
Quote in the paperSubstantial claim
- May combine two claims. 68
- Classified as probably not a substantial claim. 38
May combine two claims.
PremisecitationBacterial co-infection was detected in ~30% of cases in the 2009 H1N1 pandemic, with high mortality rates despite administration of appropriate antibiotics.
“Bacterial co-infection was also detected in ~30% of cases in the 2009 H1N1 pandemic, with high mortality rates despite administration of appropriate antibiotics”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [11] Cillóniz, 2012, Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia, J Infect source
Not checked in the free run.
- cites [12] Gill, 2010, Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections, Arch Pathol Lab Med source
Not checked in the free run.
- cites [13] Jain, 2009, Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009, N Engl J Med source
Not checked in the free run.
- cites [14] Kumar, 2009, Critically ill patients with 2009 influenza A(H1N1) infection in Canada, JAMA source
Not checked in the free run.
- cites [15] Martín-Loeches, 2011, Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus, Chest source
Not checked in the free run.
- cites [16] Palacios, 2009, Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza, PLoS ONE source
Not checked in the free run.
- cites [17] Shieh, 2010, 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States, Am J Pathol source
Not checked in the free run.
- cites [18] Domínguez-Cherit, 2009, Critically Ill patients with 2009 influenza A(H1N1) in Mexico, JAMA source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese dysbiotic changes may alter subsequent immune function against secondary bacterial infection or alter the dynamics of inter-microbial interactions, thereby enhancing the proliferation of potentially pathogenic bacterial species.
“which in turn may alter subsequent immune function against secondary bacterial infection or alter the dynamics of inter-microbial interactions, thereby enhancing the proliferation of potentially pathogenic bacterial species”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 1918-1919 H1N1 influenza pandemic resulted in more than 50 million deaths, with many caused by bacterial super-infection leading to secondary pneumonia.
“the so-called “Spanish Flu” pandemic of H1N1 influenza A virus from 1918 to 1919 resulted in more than 50 million deaths, with many caused by bacterial super-infection leading to secondary pneumonia”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [1] Brundage, 2006, Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness, Lancet Infect Dis source
Not checked in the free run.
- cites [2] Chien, 2009, Bacterial pathogens and death during the 1918 influenza pandemic, N Engl J Med source
Not checked in the free run.
- cites [3] Johnson, 2002, Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic, Bull Hist Med source
Not checked in the free run.
- cites [4] McCullers, 2006, Insights into the interaction between influenza virus and pneumococcus, Clin Microbiol Rev source
Not checked in the free run.
- cites [5] Morens, 2007, The 1918 influenza pandemic: insights for the 21st century, J Infect Dis source
Not checked in the free run.
- cites [6] Morens, 2008, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, J Infect Dis source
Not checked in the free run.
- cites [7] The origin and virulence of the 1918 “Spanish” influenza virus86112 TaubenbergerJK 17526158Proc Am Philos Soc1502006
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenSecondary bacterial infections following respiratory viral infections often have a more severe clinical course.
“which often have a more severe clinical course”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenUnique microbial communities reside on the mucosal surfaces of the gastrointestinal tract and the respiratory tract.
“unique microbial communities reside on the mucosal surfaces of the gastrointestinal tract and the respiratory tract”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationnone givenThe mechanisms underlying post-viral bacterial infections are complex and include multifactorial processes mediated by interactions between viruses, bacteria, and the host immune system.
“The mechanisms underlying post-viral bacterial infections are complex, and include multifactorial processes mediated by interactions between viruses, bacteria, and the host immune system.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicrobial metabolites are integral for promoting immune responses in the gut against pathogens, including inducing secretion of IL-18 and defensins.
“microbial metabolites are integral for promoting immune responses in the gut against pathogens, including inducing secretion of IL-18 (36) and defensins (37, 38)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [36] Kalina, 2002, Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region, Eur J Immunol source
Not checked in the free run.
- cites [37] Schauber, 2003, Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways, Gut source
Not checked in the free run.
- cites [38] Schauber, 2004, Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells, Mol Immunol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSCFAs promote the development of naive CD4+ T cells into regulatory T cells, induce "tolerogenic" dendritic cells in the intestinal mucosa, and limit autoimmunity.
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [31] Smith, 2013, The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis, Science source
Not checked in the free run.
- cites [32] Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature source
Not checked in the free run.
- cites [33] Goverse, 2017, Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells, J Immunol source
Not checked in the free run.
- cites [34] Mariño, 2017, Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes, Nat Immunol source
Not checked in the free run.
- cites [35] Haase, 2018, Impacts of microbiome metabolites on immune regulation and autoimmunity, Immunology source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenPotential mechanisms by which microbiome changes might modulate susceptibility to secondary bacterial infections include alterations in the nature and magnitude of the immune response in the host and facilitating growth of pathogens in the absence of normal commensals.
“potential mechanisms by which these changes might modulate susceptibility to secondary bacterial infections include alterations in the nature and magnitude of the immune response in the host (microbiome on host effects) and facilitating growth of pathogens in the absence of normal commensals (inter-microbial effects)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenGerm-free mice have markedly underdeveloped gut-associated lymphoid tissues, decreased number and smaller-sized Peyer's patches and mesenteric lymph nodes, and defects in antibody production, compared to specific pathogen free (SPF) mice.
“Germ-free (GF) mice (which lack microbiota) have markedly underdeveloped gut-associated lymphoid tissues, decreased number and smaller-sized Peyer's patches and mesenteric lymph nodes, and defects in antibody production, compared to specific pathogen free (SPF) mice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWild-living mice exhibit more diverse microbiomes, with significant abundance of Proteobacteria as well as Firmicutes and Bacteroidetes.
“Wild-living mice exhibit more diverse microbiomes, with significant abundance of Proteobacteria as well as Firmicutes and Bacteroidetes”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Rosshart, 2017, Wild mouse gut microbiota promotes host fitness and improves disease resistance, Cell source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenThe effects of these alterations on risk of secondary bacterial pneumonia have not been studied.
“While the effects of these alterations on risk of secondary bacterial pneumonia have not been studied”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGerm-free animals exhibit increased susceptibility to multiple types of infections, including viruses, bacteria, and parasites.
“germ-free animals exhibit increased susceptibility to multiple types of infections, including viruses, bacteria, and parasites”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (22,–27)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationShort-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate are fermentation products of dietary fiber and carbohydrates by large intestinal bacteria.
“short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate are fermentation products of dietary fiber and carbohydrates by large intestinal bacteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Cummings, 1983, Fermentation in the human large intestine: evidence and implications for health, Lancet source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningDisruptions in the normal microbial communities by an acute viral infection might contribute to the development of post-viral bacterial pneumonia.
“This raises the possibility that disruptions in the normal microbial communities by an acute viral infection might contribute to the development of post-viral bacterial pneumonia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenDuring health, the human gut bacterial community is diverse, with each individual harboring over 100 trillion bacteria, comprised of over 150 different species.
“During health, the human gut bacterial community is diverse, with each individual harboring over 100 trillion bacteria, comprised of over 150 different species.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe gastrointestinal microbiota is dominated by Firmicutes and Bacteroidetes, with lower abundances of Proteobacteria and Actinobacteria.
“The gastrointestinal microbiota is dominated by Firmicutes (e.g., Lactobacillus, Bacillus, and Clostridium) and Bacteroidetes (e.g., Bacteroides), with lower abundances of Proteobacteria (e.g., Escherichia) and Actinobacteria (e.g., Bifidobacterium)”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSegmented filamentous bacteria are critical promoters of intestinal mucosal IgA production and Th17 cell induction.
“segmented filamentous bacteria are critical promoters of intestinal mucosal IgA production (39, 40)and Th17 cell induction (41, 42)”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [39] Klaasen, 1993, Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice, Infect Immun source
Not checked in the free run.
- cites [40] Talham, 1999, Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system, Infect Immun source
Not checked in the free run.
- cites [41] Ivanov, 2009, Induction of intestinal Th17 cells by segmented filamentous bacteria, Cell source
Not checked in the free run.
- cites [42] Gaboriau-Routhiau, 2009, The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses, Immunity source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe gut microbiome plays an integral role in shaping the immune system starting early in life, with continued influence on priming the nature and robustness of immune responses throughout one's lifetime.
“The gut microbiome, in particular, has been shown to play an integral role in shaping the immune system starting early in life, with continued influence on priming the nature and robustness of immune responses throughout one's lifetime.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCompared to free-living mice or laboratory animals exposed to gut flora from wild mice, SPF animals have a more limited microbial community and are also more susceptible to inflammatory diseases, with a reduced immune repertoire including deficits in memory responses.
“compared to free-living mice or laboratory animals exposed to gut flora from wild mice, SPF animals have a more limited microbial community and are also more susceptible to inflammatory diseases, with a reduced immune repertoire including deficits in memory responses”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [21] Rosshart, 2017, Wild mouse gut microbiota promotes host fitness and improves disease resistance, Cell source
Not checked in the free run.
- cites [28] Reese, 2016, Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response, Cell Host Microbe source
Not checked in the free run.
- cites [29] Beura, 2016, Normalizing the environment recapitulates adult human immune traits in laboratory mice, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenEmerging evidence suggests that microbial communities residing on mucosal surfaces shape the rigor of immune responses and the ecological relationships between host and pathogens.
“emerging evidence suggests that our microbial communities residing on our mucosal surfaces likely shape the rigor of our immune responses and shape the ecological relationships between host and pathogens”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBacterial metabolites generated by gut commensals contribute to the maintenance of intact epithelial integrity, regulatory T-cell development, and a relatively anti-inflammatory immune state.
“bacterial metabolites generated by gut commensals contribute to the maintenance of intact epithelial integrity, regulatory T-cell development, and a relatively anti-inflammatory immune state”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenThe pathogenesis of super-infection has been attributed to direct mucosal/epithelial damage by influenza virus, increased bacterial colonization of the upper and lower respiratory tracts, and dysregulation of immune responses, which all lead to increased susceptibility to secondary bacterial infections.
“The pathogenesis of super-infection has been attributed to direct mucosal/epithelial damage by influenza virus, increased bacterial colonization of the upper and lower respiratory tracts (URT and LRT, respectively), and dysregulation of immune responses, which all lead to increased susceptibility to secondary bacterial infections.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThe effects of viral infection on the respiratory microbiome appear to be relatively modest, but detectable.
“the effects of viral infection on the respiratory microbiome appear to be relatively modest, but detectable”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThe respiratory tract harbors distinct communities of microbes, with multiple discrete ecological niches that vary in temperature, pH, oxygen tension, mucus production, and other factors.
“The respiratory tract also harbors distinct communities of microbes, with multiple discrete ecological niches (e.g., nasal cavity, oropharynx, upper airways) that vary in terms of temperature, pH, oxygen tension, mucus production, and other factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe gut microbiome plays an integral role in the development, instruction, and priming of the immune system.
“The gut microbiome, in addition to its metabolic functions in the host, plays an integral role in the development, instruction, and priming of the immune system.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe increase in Proteobacteria appears to be mediated by type I interferons (IFNs), which not only depleted anaerobic bacteria but also increased susceptibility to secondary Salmonella colitis.
“The increase in Proteobacteria appears to be mediated by type I interferons (IFNs) (18), which not only depleted anaerobic bacteria but also increased susceptibility to secondary Salmonella colitis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Domínguez-Cherit, 2009, Critically Ill patients with 2009 influenza A(H1N1) in Mexico, JAMA source
Not checked in the free run.
May combine two claims.
InterpretationcitationAntibiotic treatment prior to influenza infection ameliorated the degree of intestinal injury, but not lung injury, suggesting that gut dysbiosis contributed to local but not systemic inflammation.
“antibiotic treatment prior to influenza infection ameliorated the degree of intestinal injury, but not lung injury, suggesting that gut dysbiosis contributed to local but not systemic inflammation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenDysbiosis is associated with a variety of chronic diseases, many of which are characterized by chronic inflammation or abnormal metabolism, including inflammatory bowel disease, cardiovascular disease, and diabetes.
“Dysbiosis, or an imbalance in the normal composition of the microbiome, is associated with a variety of chronic diseases, many of which are characterized by chronic inflammation or abnormal metabolism, including inflammatory bowel disease, cardiovascular disease, and diabetes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCaloric restriction also results in increased relative abundance of Proteobacteria and increased Bacteroidetes to Firmicutes ratio, raising the possibility that decreased oral intake during influenza may contribute to changes in the microbiome.
“caloric restriction also results in increased relative abundance of Proteobacteria and increased Bacteroidetes to Firmicutes ratio, raising the possibility that decreased oral intake during influenza may contribute to changes in the microbiome”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [45] Bartley, 2017, Impact of age, caloric restriction, and influenza infection on mouse gut microbiome: an exploratory study of the role of age-related microbiome changes on influenza responses, Front Immunol source
Not checked in the free run.
- cites [47] Groves, 2018, Respiratory disease following viral lung infection alters the murine gut microbiota, Front Immunol source
Not checked in the free run.
- cites [49] Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature source
Not checked in the free run.
- cites [50] Ruiz, 2017, One-year calorie restriction impacts gut microbial composition but not its metabolic performance in obese adolescents, Environ Microbiol source
Not checked in the free run.
May combine two claims.
InterpretationcitationMacrophages from animals treated with antibiotics exhibited defective responses to type I and II IFNs and impaired capacity to limit viral replication, suggesting that intestinal microbiota provide immune stimulation that establishes an "activation threshold" for innate antiviral immune responses.
“Macrophages from animals treated with antibiotics exhibited defective responses to type I and II IFNs and impaired capacity to limit viral replication, suggesting that intestinal microbiota provide immune stimulation that establishes an “activation threshold” for innate antiviral immune responses”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Abt, 2012, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationMice given a 4 week oral course of broad-spectrum antibiotics before respiratory viral infection mounted an attenuated anti-PR8 antibody response, were incapable of inducing CD4+ T cell-mediated IFN-γ response to PR8 antigen, and had fewer influenza-specific CD8+ T cells.
“Mice given a 4 week oral course of broad-spectrum antibiotics before respiratory viral infection mounted an attenuated anti-PR8 antibody response, were incapable of inducing CD4+ T cell-mediated IFN-γ response to PR8 antigen, and had fewer influenza-specific CD8+T cells”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [51] Ichinohe, 2011, Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [52] Abt, 2012, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationIn a murine model of influenza infection, although total numbers of bacteria in the gut did not decrease, there was a reduction in quantities of segmented filamentous bacteria (SFB) and Lactobacillus/Lactococcus, accompanied by increases in Enterobacteriaceae.
“In a murine model of influenza infection, the investigators found that although the total numbers of bacteria in the gut did not decrease, there was a reduction in the quantities of segmented filamentous bacteria (SFB) and Lactobacillus/Lactococcus, accompanied by increases in Enterobacteriaceae.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenShort-term perturbations in the gut microenvironment caused by illness, antibiotic usage, or dietary changes can alter the gut microbiome and subsequently lead to transient alterations in immune responses.
“Short-term perturbations in the gut microenvironment caused by illness, antibiotic usage, or dietary changes (e.g., starvation) can alter the gut microbiome and subsequently lead to transient alterations in immune responses.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationGerm-free mice and antibiotic-treated mice exhibit impaired antibody responses to seasonal influenza vaccination, which was restored by oral administration of flagellated E. coli, demonstrating a dependence on TLR5-mediated sensing of the host microbiota.
“Germ-free mice and antibiotic-treated mice also exhibit impaired antibody responses to seasonal influenza vaccination, which was restored by oral administration of flagellated E. coli, demonstrating a dependence on TLR5-mediated sensing of the host microbiota”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Oh, 2014, TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination, Immunity source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe respiratory tract is the main site of continuous contact with exogenous microbes.
“The respiratory tract is the main site of continuous contact with exogenous microbes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSkin and oral cavity lineages are represented in the nasopharynx-e.g., Streptococcus, Staphylococcus, Corynebacterium, and Prevotella.
“Skin and oral cavity lineages are represented in the nasopharynx—e.g., Streptococcus, Staphylococcus, Corynebacterium, and Prevotella”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Charlson, 2011, Topographical continuity of bacterial populations in the healthy human respiratory tract, Am J Respir Crit Care Med source
Not checked in the free run.
- cites [72] Ling, 2013, Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates, BMC Genomics source
Not checked in the free run.
- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
May combine two claims.
PremisecitationOral administration of a probiotic cocktail containing Lactobacillus restored the immune response and enhanced the activation of signaling pathways associated with recognition of single-stranded RNA virus.
“Oral administration of a probiotic cocktail containing Lactobacillus restored the immune response and enhanced the activation of signaling pathways associated with recognition of single-stranded RNA virus”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Wu, 2013, Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection, Curr Microbiol source
Not checked in the free run.
May combine two claims.
PremisecitationClinical studies have shown that although probiotics do not influence the incidence of respiratory tract infection, they do reduce the severity of symptoms and duration of the illness.
“clinical studies have shown that although probiotics do not influence the incidence of respiratory tract infection, they do reduce the severity of symptoms and duration of the illness”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] de, 2006, Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial, Vaccine source
Not checked in the free run.
- cites [58] Vouloumanou, 2009, Probiotics for the prevention of respiratory tract infections: a systematic review, Int J Antimicrob Agents source
Not checked in the free run.
May combine two claims.
PremisecitationAntibiotic-pretreated animals displayed altered cytokine profiles in the lung compared to untreated controls following S. pneumoniae infection, including significantly decreased TNF-α levels at 6 and 24 h after infection.
“Antibiotic-pretreated animals displayed altered cytokine profiles in the lung compared to untreated controls following S. pneumoniae infection, including significantly decreased TNF-α levels at 6 and 24 h after infection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationAnimals fed a high fiber diet had increased generation of SCFAs, leading to enhanced antiviral CD8+ T cell immune responses and attenuated neutrophil-mediated lung injury during influenza infection, resulting in improved survival.
“animals fed a high fiber diet had increased generation of SCFAs, leading to enhanced antiviral CD8+ T cell immune responses and attenuated neutrophil-mediated lung injury during influenza infection, resulting in improved survival”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Trompette, 2018, Dietary fiber confers protection against flu by shaping Ly6c- patrolling monocyte hematopoiesis and CD8+ T cell metabolism, Immunity source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe oropharynx contains members of Firmicutes, Proteobacteria, and Bacteroidetes, including Streptococcus, Neisseria, Haemophilus, and Lachnospira spp.
“The oropharynx contains members of Firmicutes, Proteobacteria, and Bacteroidetes, including Streptococcus, Neisseria, Haemophilus, and Lachnospira spp.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [68] Lemon, 2010, Comparative analyses of the bacterial microbiota of the human nostril and oropharynx, MBio source
Not checked in the free run.
- cites [70] Charlson, 2011, Topographical continuity of bacterial populations in the healthy human respiratory tract, Am J Respir Crit Care Med source
Not checked in the free run.
- cites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn healthy adults, bacteria present in the nasal cavity are typically those associated with skin, predominantly members of the Actinobacteria, followed by Firmicutes, and Proteobacteria.
“In healthy adults, bacteria present in the nasal cavity are typically those associated with skin, predominantly members of the Actinobacteria (e.g., Corynebacterium spp., Propionibacterium spp.), followed by Firmicutes (e.g., Staphylococcus spp.), and Proteobacteria”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [67] Frank, 2010, The human nasal microbiota and Staphylococcus aureus carriage, PLoS ONE source
Not checked in the free run.
- cites [68] Lemon, 2010, Comparative analyses of the bacterial microbiota of the human nostril and oropharynx, MBio source
Not checked in the free run.
- cites [69] Bassis, 2014, The nasal cavity microbiota of healthy adults, Microbiome source
Not checked in the free run.
May combine two claims.
PremisecitationOral administration of Lactobacillus plantarum enhanced the type I IFN response and lowered viral titers in the lungs in a murine model of influenza infection.
“oral administration of Lactobacillus plantarum enhanced the type I IFN response and lowered viral titers in the lungs in a murine model of influenza infection”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Maeda, 2009, Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice, Int Immunopharmacol source
Not checked in the free run.
May combine two claims.
PremisecitationAntibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality.
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Steed, 2017, The microbial metabolite desaminotyrosine protects from influenza through type I interferon, Science source
Not checked in the free run.
May combine two claims.
PremisecitationMicrobiome depletion led to decreased survival, increased lung bacterial burden, and increased systemic dissemination of bacteria in mice challenged with S. pneumoniae.
“microbiome depletion led to decreased survival, increased lung bacterial burden, and increased systemic dissemination of bacteria”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenSeveral factors are known to influence airway microbiome composition including infection history, age, genetics, and structural lung disease.
“Several factors are known to influence airway microbiome composition including infection history, age, genetics, and structural lung disease.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSFB-deficient animals have increased lung bacterial burdens and more severe pneumonia when challenged with MRSA, which was associated with decreased IL-17-mediated responses in the lung.
“SFB-deficient animals have increased lung bacterial burdens and more severe pneumonia when challenged with methicillin-resistant Staphylococcus aureus (MRSA) (54), which was associated with decreased IL-17-mediated responses in the lung.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Gauguet, 2015, Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia, Infect Immun source
Not checked in the free run.
May combine two claims.
PremisecitationIn the microbiota-depleted group, alveolar macrophages and blood neutrophils exhibited decreased phagocytic activity, and decreased inflammatory cytokine production following ex vivo stimulation by TLR ligands such as LTA.
“in the microbiota-depleted group, alveolar macrophages and blood neutrophils exhibited decreased phagocytic activity, and decreased inflammatory cytokine production following ex vivo stimulation by Toll-like receptor (TLR) ligands such as lipoteichoic acid (LTA)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenThe URT and LRT have similar microbial community compositions, although microbe densities are much higher in the former in healthy hosts.
“The URT and LRT have similar microbial community compositions, although microbe densities are much higher in the former in healthy hosts.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIndividuals with chronic airway diseases (e.g., cystic fibrosis, COPD) have increased bacterial populations in the lungs and differences in the relative abundance of certain species.
“Individuals with chronic airway diseases (e.g., cystic fibrosis, COPD) have increased bacterial populations in the lungs (77) and differences in the relative abundance of certain species”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [77] Venkataraman, 2015, Application of a neutral community model to assess structuring of the human lung microbiome, MBio source
Not checked in the free run.
- cites [81] Rogers, 2015, Respiratory microbiota: addressing clinical questions, informing clinical practice, Thorax source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe major phyla in healthy lungs are Bacteroidetes and Firmicutes, which mainly include Prevotella, Veillonella, and Streptococcus.
“The major phyla in healthy lungs are Bacteroidetes and Firmicutes, which mainly include Prevotella, Veillonella, and Streptococcus”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [78] Morris, 2013, Comparison of the respiratory microbiome in healthy nonsmokers and smokers, Am J Respir Crit Care Med source
Not checked in the free run.
- cites [79] Segal, 2013, Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation, Microbiome source
Not checked in the free run.
- cites [80] Dickson, 2015, Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography, Ann Am Thorac Soc source
Not checked in the free run.
May combine two claims.
PremisecitationContrary to dogma that normal healthy lungs are a sterile environment, a distinct, and somewhat dynamic lung microbiome can be identified using sequencing technology, with microaspiration serving as the primary route of microbial immigration from the URT to the LRT.
“Contrary to dogma that normal healthy lungs are a sterile environment, a distinct, and somewhat dynamic lung microbiome can be identified using sequencing technology, with microaspiration serving as the primary route of microbial immigration from the URT to the LRT”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [76] Bassis, 2015, Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals, MBio source
Not checked in the free run.
- cites [77] Venkataraman, 2015, Application of a neutral community model to assess structuring of the human lung microbiome, MBio source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenA limited number of pathogens including Streptococcus pneumoniae, Neisseria meningitides, and Haemophilus influenzae are commensal bacteria of the URT.
“A limited number of pathogens including Streptococcus pneumoniae, Neisseria meningitides, and Haemophilus influenzae are commensal bacteria of the URT.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationBoth studies included subjects ranging from infants to adults >80 years of age, limiting conclusions about age-related effects.
“Both studies included subjects ranging from infants to adults >80 years of age, limiting conclusions about age-related effects.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Not checked in the free run.
- cites [100] Edouard, 2018, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
May combine two claims.
InterpretationreasoningUnlike other diseases where decreased diversity is considered deleterious to the host, the effects of viral infections on diversity per se are variable and not presently considered a good indicator of risk for complications, including secondary bacterial pneumonias.
“Thus, unlike other diseases where decreased diversity is considered deleterious to the host, the effects of viral infections on diversity per se are variable and not presently considered a good indicator of risk for complications, including secondary bacterial pneumonias.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationChildren with severe influenza showed decreased relative abundance of S. aureus and increased abundance of Prevotella, Streptobacillus, Porphyromonas, Granulicatella, Veillonella, Fusobacterium, and Haemophilus.
“Children with severe influenza showed decreased relative abundance of S. aureus and increased abundance of Prevotella, Streptobacillus, Porphyromonas, Granulicatella, Veillonella, Fusobacterium, and Haemophilus.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Langevin, 2017, Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study, J Gen Virol source
Not checked in the free run.
May combine two claims.
PremisecitationRSV-infected mice who underwent antibiotic-mediated depletion of Streptococcus viridans in the nasopharynx exhibited increases in number of inflammatory lymphocytes and airway hyperresponsiveness, and decreases in regulatory T cell number and transforming growth factor-β production.
“RSV-infected mice who underwent antibiotic-mediated depletion of Streptococcus viridans in the nasopharynx exhibited increases in number of inflammatory lymphocytes and airway hyperresponsiveness, and decreases in regulatory T cell number and transforming growth factor-β production”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Ni, 2012, Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection, PLoS ONE source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of mice colonized with S. pneumoniae and then infected with influenza A virus 3 days after, S. pneumoniae transmission occurred only when all mice were infected with influenza and was blocked by an influenza-neutralizing antibody.
“In a study of mice colonized with S. pneumoniae and then infected with influenza A virus 3 days after, S. pneumoniae transmission occurred only when all mice were infected with influenza and was blocked by an influenza-neutralizing antibody”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Diavatopoulos, 2010, Influenza A virus facilitates Streptococcus pneumoniae transmission and disease, FASEB J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn healthy children, the major phyla among nasopharyngeal microbiotas are Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, and Fusobacteria, with Moraxella, Haemophilus, Streptococcus, Flavobacteria, Dolosigranulum, Corynebacterium, and Neisseria as predominant genera.
“In healthy children, the major phyla among nasopharyngeal microbiotas are Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, and Fusobacteria, with Moraxella, Haemophilus, Streptococcus, Flavobacteria, Dolosigranulum, Corynebacterium, and Neisseria as predominant genera.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Bogaert, 2011, Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis, PLoS ONE source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningAnother complicating factor particularly in cross-sectional studies examining the microbiome during viral infections is that the groups are not well-controlled and the sample numbers are relatively small considering the number of variables that could affect the respiratory tract microbiome.
“Another complicating factor particularly in cross-sectional studies examining the microbiome during viral infections is that the groups are not well-controlled and the sample numbers are relatively small considering the number of variables that could affect the respiratory tract microbiome–such as age, gender, oral hygiene and nose-picking habits, healthcare-based employment status, smoking status”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMean relative abundances of Haemophilus, Moraxella, Staphylococcus, and Corynebacterium varied significantly between summer and fall samples and between age groups.
“although mean relative abundances of Haemophilus, Moraxella, Staphylococcus, and Corynebacterium varied significantly between summer and fall samples and between age groups.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Pérez-Losada, 2017, Nasopharyngeal microbiome diversity changes over time in children with asthma, PLoS ONE source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThe underlying type of viral infection, sampling timepoint after onset of infection, severity of infection, and concomitant antimicrobial usage are confounding factors.
“The underlying type of viral infection, sampling timepoint after onset of infection, severity of infection, and concomittant antimicrobial usage are other confounding factors.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThese studies demonstrated that there was considerable inter-subject variability, highlighting the need for longitudinal studies to decipher changes following viral infection.
“However, these studies demonstrated that there was considerable inter-subject variability, highlighting the need for longitudinal studies to decipher changes following viral infection.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
Not checked in the free run.
- cites [109] Chaban, 2013, Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza, PLoS ONE source
Not checked in the free run.
- cites [110] Greninger, 2010, A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America, PLoS ONE source
Not checked in the free run.
May combine two claims.
PremisecitationAn investigation of the frequency and seasonal variation in bacterial and viral load in asymptomatic healthcare professionals during the winter and summer months showed that of the 100 subjects tested during the winter, 34 were colonized with at least one bacterial species and 11 tested positive for at least one virus.
“An investigation of the frequency and seasonal variation in bacterial and viral load in asymptomatic healthcare professionals during the winter and summer months showed that of the 100 subjects tested during the winter, 34 were colonized with at least one bacterial species and 11 tested positive for at least one virus.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Hassoun, 2015, Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study, Am J Infect Control source
Not checked in the free run.
May combine two claims.
PremisecitationIn the nasopharyngeal compartment of Aboriginal and non-Aboriginal children in Australia, positive associations were detected between hRV and S. pneumoniae, H. influenza, and Moraxella catarrhalis carriage as well as between adenovirus and M. catarrhalis.
“In the nasopharyngeal compartment of Aboriginal and non-Aboriginal children in Australia, positive associations were detected between hRV and S. pneumoniae, H. influenza, and Moraxella catarrhalis carriage as well as between adenovirus and M. catarrhalis (111).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Jacoby, 2007, Kalgoorlie Otitis Media Research Project Team. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract, Vaccine source
Not checked in the free run.
May combine two claims.
PremisecitationThese profiles were not associated with virus type but were linked to the age of subjects.
“These profiles, however, were not associated with virus type but were linked to the age of subjects (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Not checked in the free run.
May combine two claims.
PremisecitationChanges in nasopharyngeal microbiome diversity were observed across seasons, with a predominance of Proteobacteria and Fusobacteria in fall-winter and Bacteroidetes and Firmicutes in spring; these differences were independent of recent antibiotics and viral co-infection.
“Changes in nasopharyngeal microbiome diversity were observed across seasons, with a predominance of Proteobacteria and Fusobacteria in fall-winter and Bacteroidetes and Firmicutes in spring; these differences were independent of recent antibiotics and viral co-infection (114).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Bogaert, 2011, Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis, PLoS ONE source
Not checked in the free run.
May combine two claims.
PremisecitationIn a mouse model, bacterial density in the nasopharynx after LAIV administration was increased as much as 100,000 times compared to influenza-naive hosts, and the duration of carriage of S. pneumoniae or S. aureus was also increased 2 to 5-fold.
“In a mouse model, bacterial density in the nasopharynx after LAIV administration was increased as much as 100,000 times compared to influenza-naive hosts, and the duration of carriage of S. pneumoniae or S. aureus was also increased 2 to 5-fold (121).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [121] Mina, 2014, Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice, MBio source
Not checked in the free run.
May combine two claims.
PremisecitationIn healthy adult volunteers, intranasal LAIV administration induced an increase in the diversity of the nasopharyngeal microbiome, as well as relative abundances of Staphylococcus and Bacteroides.
“In healthy adult volunteers, it was demonstrated that intranasal LAIV administration induced an increase in the diversity of the nasopharyngeal microbiome, as well as relative abundances of Staphylococcus and Bacteroides (107).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Not checked in the free run.
May combine two claims.
PremisecitationNasopharyngeal sampling showed decreased relative abundance of Haemophilus and Neisseria spp., but an increase in the normal nasal commensal, Propionibacterium, in subjects following hRV infection.
“Nasopharyngeal sampling showed completely opposite results, with decreased relative abundance of Haemophilus and Neisseria spp., but an increase in the normal nasal commensal, Propionibacterium, in subjects following hRV infection (73).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Not checked in the free run.
May combine two claims.
PremisecitationAdministration of live attenuated influenza vaccine (LAIV), which is nasally instilled, to healthy children increased the nasal colonization density of S. pneumoniae in subjects who harbored this bacterium at the time of vaccination, and transiently increased rates of colonization by H. influenza.
“Administration of live attenuated influenza vaccine (LAIV), which is nasally instilled, to healthy children increased the nasal colonization density of S. pneumoniae in subjects who harbored this bacterium at the time of vaccination, and transiently increased rates of colonization by H. influenza (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Thors, 2016, The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds. a randomized controlled trial, Am J Respir Crit Care Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn contrast, of the 100 subjects tested during the summer, 37 harbored at least one bacterium (mainly MRSA and K. pneumoniae) and four tested positive for one virus.
“In contrast, of the 100 subjects tested during the summer, 37 harbored at least one bacterium (mainly MRSA and K. pneumoniae) and four tested positive for one virus (116).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Hassoun, 2015, Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study, Am J Infect Control source
Not checked in the free run.
May combine two claims.
PremisecitationIn the oropharyngeal compartment, rhinovirus infection was associated with a strong trend toward transient increases in the relative abundances of H. parainfluenzae, Neisseria subflava and a weak trend toward an increase in S. aureus.
“In the oropharyngeal compartment, rhinovirus infection was associated with a strong trend toward transient increases in the relative abundances of H. parainfluenzae, Neisseria subflava and a weak trend toward an increase in S. aureus (119).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Hofstra, 2015, Changes in microbiota during experimental human Rhinovirus infection, BMC Infect Dis source
Not checked in the free run.
May combine two claims.
PremisecitationAnother study of 31 families with small children using longitudinal nasal swab sampling demonstrated that rhinovirus infection was associated with increased acquisition of S. pneumoniae from the community as well as increased transmission of S. pneumoniae within the family.
“Another study of 31 families with small children using longitudinal nasal swab sampling demonstrated that rhinovirus infection was associated with increased acquisition of S. pneumoniae from the community as well as increased transmission of S. pneumoniae within the family (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Karppinen, 2017, Acquisition and transmission of streptococcus pneumoniae are facilitated during rhinovirus infection in families with children, Am J Respir Crit Care Med source
Not checked in the free run.
May combine two claims.
PremisecitationThe percentage of colonized children and bacterial density were also higher at asymptomatic visits in which virus was detected than at those in which virus was not detected.
“Interestingly, the percentage of colonized children and bacterial density were also higher at asymptomatic visits in which virus was detected than at those in which virus was not detected (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] DeMuri, 2018, Dynamics of bacterial colonization with streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection, Clin Infect Dis source
Not checked in the free run.
May combine two claims.
PremisecitationIn subjects with chronic obstructive pulmonary disease (COPD) after hRV infection but not in healthy individuals, there was an increase in bacterial burden and growth of bacteria present at baseline, particularly H. influenzae.
“In subjects with chronic obstructive pulmonary disease (COPD) after hRV infection but not in healthy individuals, there was an increase in bacterial burden and growth of bacteria present at baseline, particularly H. influenzae (124).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [124] Molyneaux, 2013, Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med source
Not checked in the free run.
May combine two claims.
PremisecitationMucus production in the respiratory tract is increased to facilitate viral clearance during infections, but excessive mucus production can lead to airway obstruction by impeding mucociliary clearance.
“First, mucus production in the respiratory tract is increased to facilitate viral clearance during infections. However, excessive mucus production can lead to airway obstruction by impeding mucociliary clearance (125).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] Vareille, 2011, The airway epithelium: soldier in the fight against respiratory viruses, Clin Microbiol Rev source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased upper respiratory tract persistence of S. aureus as well as increased risk of S. aureus pneumonia was observed in flu-infected wildtype mice compared to mice lacking the type III IFN receptor.
“Increased upper respiratory tract persistence of S. aureus as well as increased risk of S. aureus pneumonia was observed in flu-infected wildtype mice compared to mice lacking the type III IFN receptor (123).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [123] Planet, 2016, Lambda interferon restructures the nasal microbiome and increases susceptibility to staphylococcus aureus superinfection, MBio source
Not checked in the free run.
May combine two claims.
InterpretationreasoningRespiratory viruses not only alter the bacterial community in the URT, but also promote bacterial colonization of the LRT by a variety of mechanisms that impair bacterial clearance.
“Respiratory viruses not only alter the bacterial community in the URT, but also promote bacterial colonization of the LRT by a variety of mechanisms that impair bacterial clearance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningCompared to studies of the URT microbiome, studies of the LRT microbiome following viral infections are relatively scarce due to the difficulty of obtaining uncontaminated samples from the lung.
“Compared to studies of the URT microbiome, studies of the LRT microbiome following viral infections are relatively scarce due to the difficulty of obtaining uncontaminated samples from the lung.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationViral infections can reduce ciliary beat frequency and the number of ciliated cells, disrupt the coordinated movement of cilia, and impede the repair of respiratory epithelial cells, further leading to reduced mucociliary clearance.
“Second, viral infections can also reduce ciliary beat frequency and the number of ciliated cells, disrupt the coordinated movement of cilia, and impede the repair of respiratory epithelial cells, further leading to reduced mucociliary clearance (126, 127).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [126] Pittet, 2010, Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae, Am J Respir Cell Mol Biol source
Not checked in the free run.
- cites [127] Smith, 2014, Ciliary dyskinesia is an early feature of respiratory syncytial virus infection, Eur Respir J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSamples of convenience, such as sputum, suffer from oral contamination, but bronchoscopic samples are invasive and expensive to obtain on a regular basis.
“Samples of convenience, such as sputum, suffer from oral contamination, but bronchoscopic samples are invasive and expensive to obtain on a regular basis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationC. pseudodiphtheriticum inhibited S. aureus growth, whereas C. accolens and S. aureus appeared to support each other's growth.
“Subsequent studies by another group reported that C. pseudodiphtheriticum inhibited S. aureus growth, whereas C. accolens and S. aureus appeared to support each other's growth (139).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [139] Yan, 2013, Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage, Cell Host Microbe source
Not checked in the free run.
May combine two claims.
InterpretationcitationInfluenza infection perturbs the respiratory microbiome, leading to the production of secondary metabolites including immune-modulating molecules.
“These data imply that influenza infection perturbs the respiratory microbiome, leading to the production of secondary metabolites including immune-modulating molecules.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
Not checked in the free run.
May combine two claims.
PremisecitationA recent preclinical study using a murine model of RSV and S. pneumoniae superinfection employed nasal priming by a C. pseudodiphtheriticum strain to augment host defense against the viral infection, which enhanced clearance of secondary bacterial challenge and reduced lung injury measures.
“Interestingly, a recent preclinical study using a murine model of RSV and S. pneumoniae superinfection employed nasal priming by a C. pseudodiphtheriticum strain to augment host defense against the viral infection, which enhanced clearance of secondary bacterial challenge and reduced lung injury measures (140).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] Kanmani, 2017, Respiratory commensal bacteria corynebacterium pseudodiphtheriticum improves resistance of infant mice to respiratory syncytial virus and streptococcus pneumoniae superinfection, Front Microbiol source
Not checked in the free run.
May combine two claims.
PremisecitationCorynebacterium spp. were enriched in children who were not nasally colonized with pneumococcus, and C. accolens inhibit S. pneumoniae growth in vitro by expressing a lipase that releases free fatty acids from skin surface triacylglycerols, which inhibit pneumococcal growth.
“Conversely, other investigators observed that Corynebacterium spp. were enriched in children who were not nasally colonized with pneumococcus, and demonstrated that C. accolens inhibit S. pneumoniae growth in vitro by expressing a lipase that releases free fatty acids from skin surface triacylglycerols, which inhibit pneumococcal growth.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe mechanism of eradication appeared to be bacteriocin-independent.
“The mechanism appeared to be bacteriocin-independent.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] Uehara, 2000, Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp, J Hosp Infect source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningIt is possible that the immune response incited by acute viral infections, changes in the host epithelial surface caused by the virus, or the virus itself might lead to elimination of a host commensal that is responsible for keeping pathobionts in check.
“Thus, it is possible that the immune response incited by acute viral infections, changes in the host epithelial surface caused by the virus, or the virus itself might lead to elimination of a host commensal that is responsible for keeping pathobionts in check.”
Quote in the paperSubstantial claim- Rests on an assumption: Interspecies competition maintains homeostasis of the microbial community, preventing one microbe from dominating the community.
May combine two claims.
PremisecitationViruses impair bacterial biofilm formation and disrupt existing biofilm.
“Viruses have also been found to impair bacterial biofilm formation and disrupt existing biofilm (141–144).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [141] Reddinger, 2016, Host physiologic changes induced by influenza a virus lead to staphylococcus aureus biofilm dispersion and transition from asymptomatic colonization to invasive disease, MBio source
Not checked in the free run.
- cites [142] Pettigrew, 2014, Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection, Infect Immun source
Not checked in the free run.
- cites [143] Marks, 2013, Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease, MBio source
Not checked in the free run.
- cites [144] Reddinger, 2018, Streptococcus pneumoniae modulates staphylococcus aureus biofilm dispersion and the transition from colonization to invasive disease, MBio source
Not checked in the free run.
The paper relies on this without support.
Bacterial pneumonia frequently arises as a result of aspirated bacterial pathogens.
“Given that bacterial pneumonia frequently arises as a result of aspirated bacterial pathogens, a potential mechanism by which viral infections might increase the risk of secondary bacterial infections is through increased colonization of the upper respiratory tract by bacterial pathogens.”
The paper relies on this without support.
Interspecies competition maintains homeostasis of the microbial community, preventing one microbe from dominating the community.
“However, interspecies competition also maintains homeostasis of the microbial community, either through their abilities to capture scare resources (e.g., iron), or targeted killing of other bacteria (e.g., bacteriocins), preventing one microbe from dominating the community.”
The paper relies on this without support.
Mechanisms have evolved in bacteria that confer competitive advantages, permitting them to survive in an otherwise inhospitable host environment.
“It has long been appreciated that mechanisms have evolved in bacteria that confer competitive advantages, permitting them to survive in an otherwise inhospitable host environment.”
The paper relies on this without support.
Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.
“Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Influenza is the most common type of acute respiratory infection.
“Influenza is the most common type of acute respiratory infection (Hanada et al., 2018)”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Hanada et al., 2018
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · see citing works
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · see citing works
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · see citing works
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554 · see citing works
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685 · see citing works
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980 · see citing works
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
Bogaert, D., de Groot, R., & Hermans, P. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00938-7 · Cited by 1,929 · cited 1× · see citing works
“Nonetheless, bacterial colonization of the URT is generally considered as the first step in the development of invasive bacterial infections (83, 84), including secondary bacterial infections following respiratory viral infection.”
BackgroundHospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700 · see citing works
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 1× · see citing works
“It is estimated that the so-called "Spanish Flu" pandemic of H1N1 influenza A virus from 1918 to 1919 resulted in more than 50 million deaths, with many caused by bacterial superinfection leading to secondary pneumonia (1) (2) (3) (4) (5) (6) (7) .”
BackgroundMicrobiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502 · see citing works
Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452 · see citing works
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425 · see citing works
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., & Weiser, J. N. (2010) · Nature Medicine · doi:10.1038/nm.2087 · Cited by 1,154 · see citing works
Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144 · see citing works
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Beura, L. K., Hamilton, S. E., Bi, K., Schenkel, J. M., Odumade, O. A., Casey, K. A., Thompson, E. A., Fraser, K. A., Rosato, P. C., Filali-Mouhim, A., et al. (2016) · Nature · doi:10.1038/nature17655 · Cited by 1,072 · see citing works
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993 · see citing works
Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T., & Mizunoe, Y. (2010) · Nature · doi:10.1038/nature09074 · Cited by 991 · see citing works
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Rosshart, S. P., Vassallo, B. G., Angeletti, D., Hutchinson, D. S., Morgan, A. P., Takeda, K., Hickman, H. D., McCulloch, J. A., Badger, J. H., Ajami, N. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.016 · Cited by 862 · see citing works
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846 · see citing works
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840 · see citing works
Bassis, C. M., Erb-Downward, J. R., Dickson, R. P., Freeman, C. M., Schmidt, T. M., Young, V. B., Beck, J. M., Curtis, J. L., & Huffnagle, G. B. (2015) · mBio · doi:10.1128/mbio.00037-15 · Cited by 839 · see citing works
The Gut Microbiota Plays a Protective Role in the Host Defence Against Pneumococcal Pneumonia
Schuijt, T. J., Lankelma, J. M., Scicluna, B. P., de Sousa e Melo, F., Roelofs, J. J. T. H., de Boer, J. D., Hoogendijk, A. J., de Beer, R., de Vos, A., Belzer, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309728 · Cited by 832 · see citing works
Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
Morris, A., Beck, J. M., Schloss, P. D., Campbell, T. B., Crothers, K., Curtis, J. L., Flores, S. C., Fontenot, A. P., Ghedin, E., Huang, L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1913oc · Cited by 822 · see citing works
The microbiome in infectious disease and inflammation
Honda, K., & Littman, D. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074937 · Cited by 791 · see citing works
Mariño, E., Richards, J. L., McLeod, K. H., Stanley, D., Yap, Y. A., Knight, J., McKenzie, C., Kranich, J., Oliveira, A. C., Rossello, F. J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3713 · Cited by 686 · see citing works
Trompette, A., Gollwitzer, E. S., Pattaroni, C., Lopez-Mejia, I. C., Riva, E., Pernot, J., Ubags, N., Fajas, L., Nicod, L. P., & Marsland, B. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.022 · Cited by 678 · see citing works
The airway epithelium: soldier in the fight against respiratory viruses
Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-10 · Cited by 655 · see citing works
Sun, K., & Metzger, D. W. (2008) · Nature Medicine · doi:10.1038/nm1765 · Cited by 587 · see citing works
The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., et al. (2017) · Science · doi:10.1126/science.aam5336 · Cited by 569 · see citing works
Dickson, R. P., Erb-Downward, J. R., Freeman, C. M., McCloskey, L., Beck, J. M., Huffnagle, G. B., & Curtis, J. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201501-029oc · Cited by 567 · see citing works
Bacterial topography of the healthy human lower respiratory tract
Dickson, R. P., Erb-Downward, J. R., Freeman, C. M., McCloskey, L., Falkowski, N. R., Huffnagle, G. B., & Curtis, J. L. (2017) · mBio · doi:10.1128/mbio.02287-16 · Cited by 548 · see citing works
Oh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. A., Maddur, M. S., Bower, M., Hakimpour, P., Gill, K. P., Nakaya, H. I., Yarovinsky, F., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.009 · Cited by 541 · see citing works
The 1918 Influenza Pandemic: Insights for the 21st Century
Morens, D. M., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511989 · Cited by 536 · see citing works
Wang, J., Li, F., Wei, H., Lian, Z.-X., Sun, R., & Tian, Z. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140625 · Cited by 490 · see citing works
Segal, L. N., Alekseyenko, A. V., Clemente, J. C., Kulkarni, R., Wu, B., Chen, H., Berger, K. I., Goldring, R. M., Rom, W. N., Blaser, M. J., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-19 · Cited by 482 · see citing works
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479 · see citing works
Self-citationVariability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis
Bogaert, D., Keijser, B., Huse, S., Rossen, J., Veenhoven, R., van Gils, E., Bruin, J., Montijn, R., Bonten, M., & Sanders, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017035 · Cited by 454 · see citing works
2009 Pandemic Influenza A (H1N1)
Shieh, W.-J., Blau, D. M., Denison, A. M., DeLeon-Carnes, M., Adem, P., Bhatnagar, J., Sumner, J., Liu, L., Patel, M., Batten, B., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100115 · Cited by 429 · see citing works
Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome
Venkataraman, A., Bassis, C. M., Beck, J. M., Young, V. B., Curtis, J. L., Huffnagle, G. B., & Schmidt, T. M. (2015) · mBio · doi:10.1128/mbio.02284-14 · Cited by 428 · see citing works
Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections
Gill, J. R., Sheng, Z.-M., Ely, S. F., Guinee, D. G., Beasley, M. B., Suh, J., Deshpande, C., Mollura, D. J., Morens, D. M., Bray, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.235 · Cited by 426 · see citing works
The Human Nasal Microbiota and Staphylococcus aureus Carriage
Frank, D. N., Feazel, L. M., Bessesen, M. T., Price, C. S., Janoff, E. N., & Pace, N. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010598 · Cited by 422 · see citing works
Abreu, N. A., Nagalingam, N. A., Song, Y., Roediger, F. C., Pletcher, S. D., Goldberg, A. N., & Lynch, S. V. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003783 · Cited by 415 · see citing works
Talham, G. L., Jiang, H.-Q., Bos, N. A., & Cebra, J. J. (1999) · Infection and Immunity · doi:10.1128/iai.67.4.1992-2000.1999 · Cited by 408 · see citing works
Didierlaurent, A., Goulding, J., Patel, S., Snelgrove, R., Low, L., Bebien, M., Lawrence, T., van Rijt, L. S., Lambrecht, B. N., Sirard, J.-C., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070891 · Cited by 399 · see citing works
Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections
Ghoneim, H. E., Thomas, P. G., & McCullers, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300014 · Cited by 394 · see citing works
Molyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A. G., Homola, D., Trujillo-Torralbo, M.-B., Elkin, S., Kon, O. M., Cookson, W. O. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0341oc · Cited by 390 · see citing works
Brundage, J. F. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70466-2 · Cited by 386 · see citing works
Schauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383 · see citing works
The microbiota protects against respiratory infection via GM-CSF signaling
Brown, R. L., Sequeira, R. P., & Clarke, T. B. (2017) · Nature Communications · doi:10.1038/s41467-017-01803-x · Cited by 378 · see citing works
Avadhanula, V., Rodriguez, C. A., DeVincenzo, J. P., Wang, Y., Webby, R. J., Ulett, G. C., & Adderson, E. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1629-1636.2006 · Cited by 357 · see citing works
Yan, M., Pamp, S. J., Fukuyama, J., Hwang, P. H., Cho, D.-Y., Holmes, S., & Relman, D. A. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.005 · Cited by 351 · see citing works
Fermentation in the human large intestine: evidence and implications for health
Cummings, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92478-9 · Cited by 336 · see citing works
MYTH OF THE MARSUPIAL MOTHER: HOME CARE OF VERY LOW BIRTH WEIGHT BABIES IN BOGOTA, COLOMBIA
Whitelaw, A. C., & Sleath, K. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92877-6 · Cited by 324 · see citing works
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx
Lemon, K. P., Klepac-Ceraj, V., Schiffer, H. K., Brodie, E. L., Lynch, S. V., & Kolter, R. (2010) · mBio · doi:10.1128/mbio.00129-10 · Cited by 322 · see citing works
Nakamura, S., Davis, K. M., & Weiser, J. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57762 · Cited by 280 · see citing works
Deriu, E., Boxx, G. M., He, X., Pan, C., Benavidez, S. D., Cen, L., Rozengurt, N., Shi, W., & Cheng, G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005572 · Cited by 280 · see citing works
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza
Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A. V., Kapoor, V., Hui, J., Tokarz, R., Briese, T., Baumeister, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008540 · Cited by 275 · see citing works
Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation
Osborne, L. C., Monticelli, L. A., Nice, T. J., Sutherland, T. E., Siracusa, M. C., Hepworth, M. R., Tomov, V. T., Kobuley, D. E., Tran, S. V., Bittinger, K. L., et al. (2014) · Science · doi:10.1126/science.1256942 · Cited by 271 · see citing works
Yildiz, S., Mazel-Sanchez, B., Kandasamy, M., Manicassamy, B., & Schmolke, M. (2018) · Microbiome · doi:10.1186/s40168-017-0386-z · Cited by 264 · see citing works
Respiratory disease following viral lung infection alters the murine gut microbiota
Groves, H. T., Cuthbertson, L., James, P., Moffatt, M. F., Cox, M. J., & Tregoning, J. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00182 · Cited by 258 · see citing works
The origin and virulence of the 1918 "Spanish" influenza virus.
Taubenberger, J. K. (2006) · PubMed · Cited by 254 · see citing works
Reese, T. A., Bi, K., Kambal, A., Filali-Mouhim, A., Beura, L. K., Bürger, M. C., Pulendran, B., Sekaly, R.-P., Jameson, S. C., Masopust, D., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.003 · Cited by 246 · see citing works
Marks, L. R., Davidson, B. A., Knight, P. R., & Hakansson, A. P. (2013) · mBio · doi:10.1128/mbio.00438-13 · Cited by 240 · see citing works
Wang, J., Li, F., Sun, R., Gao, X., Wei, H., Li, L.-J., & Tian, Z. (2013) · Nature Communications · doi:10.1038/ncomms3106 · Cited by 239 · see citing works
Impacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239 · cited 1× · see citing works
“In addition to being a major energy source for intestinal epithelial cells, SCFAs promote the development of naive CD4 T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
BackgroundMcNamee, L. A., & Harmsen, A. G. (2006) · Infection and Immunity · doi:10.1128/iai.00789-06 · Cited by 233 · see citing works
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice
Klaasen, H. L., Van der Heijden, P. J., Stok, W., Poelma, F. G., Koopman, J. P., Van den Brink, M. E., Bakker, M. H., Eling, W. M., & Beynen, A. C. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.303-306.1993 · Cited by 231 · see citing works
Uehara, Y., Nakama, H., Agematsu, K., Uchida, M., Kawakami, Y., Abdul Fattah, A. S. M., & Maruchi, N. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0680 · Cited by 229 · see citing works
McCullers, J. A., McAuley, J. L., Browall, S., Iverson, A. R., Boyd, K. L., & Henriques Normark, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656333 · Cited by 218 · see citing works
Pittet, L. A., Hall-Stoodley, L., Rutkowski, M. R., & Harmsen, A. G. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0417oc · Cited by 216 · see citing works
Wu, J., Meng, Z., Jiang, M., Zhang, E., Trippler, M., Broering, R., Bucchi, A., Krux, F., Dittmer, U., Yang, D., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03179.x · Cited by 213 · see citing works
The nasal cavity microbiota of healthy adults
Bassis, C. M., Tang, A. L., Young, V. B., & Pynnonen, M. A. (2014) · Microbiome · doi:10.1186/2049-2618-2-27 · Cited by 209 · see citing works
Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia
Gauguet, S., D'Ortona, S., Ahnger-Pier, K., Duan, B., Surana, N. K., Lu, R., Cywes-Bentley, C., Gadjeva, M., Shan, Q., Priebe, G. P., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00037-15 · Cited by 208 · see citing works
van den Bergh, M. R., Biesbroek, G., Rossen, J. W. A., de Steenhuijsen Piters, W. A. A., Bosch, A. A. T. M., van Gils, E. J. M., Wang, X., Boonacker, C. W. B., Veenhoven, R. H., Bruin, J. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047711 · Cited by 208 · see citing works
Vu, H. T. T., Yoshida, L. M., Suzuki, M., Nguyen, H. A. T., Nguyen, C. D. L., Nguyen, A. T. T., Oishi, K., Yamamoto, T., Watanabe, K., Vu, T. D., et al. (2011) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f111a2 · Cited by 208 · see citing works
Martín-Loeches, I., Sanchez-Corral, A., Diaz, E., Granada, R. M., Zaragoza, R., Villavicencio, C., Albaya, A., Cerdá, E., Catalán, R. M., Luque, P., et al. (2011) · Chest · doi:10.1378/chest.10-1396 · Cited by 203 · see citing works
de Vrese, M., Winkler, P., Rautenberg, P., Harder, T., Noah, C., Laue, C., Ott, S., Hampe, J., Schreiber, S., Heller, K., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.048 · Cited by 201 · see citing works
BACTERIOLOGY AND HISTOPATHOLOGY OF THE RESPIRATORY TRACT AND LUNGS IN FATAL ASIAN INFLUENZA
Hers, J. F. P., Masurel, N., & Mulder, J. (1958) · The Lancet · doi:10.1016/s0140-6736(58)92404-8 · Cited by 201 · see citing works
Goverse, G., Molenaar, R., Macia, L., Tan, J., Erkelens, M. N., Konijn, T., Knippenberg, M., Cook, E. C. L., Hanekamp, D., Veldhoen, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600165 · Cited by 200 · see citing works
A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America
Greninger, A. L., Chen, E. C., Sittler, T., Scheinerman, A., Roubinian, N., Yu, G., Kim, E., Pillai, D. R., Guyard, C., Mazzulli, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013381 · Cited by 193 · see citing works
Influenza A virus facilitates <i>Streptococcus pneumoniae</i> transmission and disease
Diavatopoulos, D. A., Short, K. R., Price, J. T., Wilksch, J. J., Brown, L. E., Briles, D. E., Strugnell, R. A., & Wijburg, O. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-146779 · Cited by 192 · see citing works
Wolter, N., Tempia, S., Cohen, C., Madhi, S. A., Venter, M., Moyes, J., Walaza, S., Malope-Kgokong, B., Groome, M., du Plessis, M., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu326 · Cited by 186 · see citing works
Maeda, N., Nakamura, R., Hirose, Y., Murosaki, S., Yamamoto, Y., Kase, T., & Yoshikai, Y. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.04.015 · Cited by 179 · see citing works
Ishizuka, S., Yamaya, M., Suzuki, T., Takahashi, H., Ida, S., Sasaki, T., Inoue, D., Sekizawa, K., Nishimura, H., & Sasaki, H. (2003) · The Journal of Infectious Diseases · doi:10.1086/379833 · Cited by 174 · see citing works
Hori, T., Kiyoshima, J., Shida, K., & Yasui, H. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.1.105-108.2002 · Cited by 145 · see citing works
Bacterial Pathogens and Death during the 1918 Influenza Pandemic
Chien, Y.-W., Klugman, K. P., & Morens, D. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0908216 · Cited by 143 · see citing works
Kanmani, P., Clua, P., Vizoso-Pinto, M. G., Rodriguez, C., Alvarez, S., Melnikov, V., Takahashi, H., Kitazawa, H., & Villena, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01613 · Cited by 140 · see citing works
Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously
Wang, J. H., Kwon, H. J., & Jang, Y. J. (2009) · The Laryngoscope · doi:10.1002/lary.20498 · Cited by 136 · see citing works
DeMuri, G. P., Gern, J. E., Eickhoff, J. C., Lynch, S. V., & Wald, E. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix941 · Cited by 136 · see citing works
Probiotics for the prevention of respiratory tract infections: a systematic review
Vouloumanou, E. K., Makris, G. C., Karageorgopoulos, D. E., & Falagas, M. E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.005 · Cited by 131 · see citing works
Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates
Ling, Z., Liu, X., Luo, Y., Yuan, L., Nelson, K. E., Wang, Y., Xiang, C., & Li, L. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-390 · Cited by 127 · see citing works
Edouard, S., Million, M., Bachar, D., Dubourg, G., Michelle, C., Ninove, L., Charrel, R., & Raoult, D. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3305-8 · Cited by 124 · see citing works
Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge
Allen, E. K., Koeppel, A. F., Hendley, J. O., Turner, S. D., Winther, B., & Sale, M. M. (2014) · Microbiome · doi:10.1186/2049-2618-2-22 · Cited by 118 · see citing works
Wu, S., Jiang, Z.-Y., Sun, Y.-F., Yu, B., Chen, J., Dai, C.-Q., Wu, X.-L., Tang, X.-L., & Chen, X.-Y. (2013) · Current Microbiology · doi:10.1007/s00284-013-0380-z · Cited by 116 · see citing works
Planet, P. J., Parker, D., Cohen, T. S., Smith, H., Leon, J. D., Ryan, C., Hammer, T. J., Fierer, N., Chen, E. I., & Prince, A. S. (2016) · mBio · doi:10.1128/mbio.01939-15 · Cited by 113 · see citing works
Pettigrew, M. M., Marks, L. R., Kong, Y., Gent, J. F., Roche-Hakansson, H., & Hakansson, A. P. (2014) · Infection and Immunity · doi:10.1128/iai.02225-14 · Cited by 110 · see citing works
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells
Schauber, J., Iffland, K., Frisch, S., Kudlich, T., Schmausser, B., Eck, M., Menzel, T., Gostner, A., Lührs, H., & Scheppach, W. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.005 · Cited by 109 · see citing works
Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic
BISNO, A. L., GRIFFIN, J. P., VAN EPPS, K. A., NIELL, H. B., & RYTEL, M. W. (1971) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197105000-00004 · Cited by 105 · see citing works
Ciliary dyskinesia is an early feature of respiratory syncytial virus infection
Smith, C. M., Kulkarni, H., Radhakrishnan, P., Rutman, A., Bankart, M. J., Williams, G., Hirst, R. A., Easton, A. J., Andrew, P. W., & O’Callaghan, C. (2014) · European Respiratory Journal · doi:10.1183/09031936.00205312 · Cited by 103 · see citing works
Rosas-Salazar, C., Shilts, M. H., Tovchigrechko, A., Schobel, S., Chappell, J. D., Larkin, E. K., Shankar, J., Yooseph, S., Nelson, K. E., Halpin, R. A., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw456 · Cited by 102 · see citing works
Abramson, J. S., Mills, E. L., Giebink, G. S., & Quie, P. G. (1982) · Infection and Immunity · doi:10.1128/iai.35.1.350-355.1982 · Cited by 96 · see citing works
Jacoby, P., Watson, K., Bowman, J., Taylor, A., Riley, T. V., Smith, D. W., & Lehmann, D. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.020 · Cited by 96 · see citing works
Respiratory microbiota: addressing clinical questions, informing clinical practice
Rogers, G. B., Shaw, D., Marsh, R. L., Carroll, M. P., Serisier, D. J., & Bruce, K. D. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205826 · Cited by 96 · see citing works
Bacterial sinusitis and otitis media following influenza virus infection in ferrets
Peltola, V. T., Boyd, K. L., McAuley, J. L., Rehg, J. E., & McCullers, J. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2562-2567.2006 · Cited by 95 · see citing works
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
Cillóniz, C., Ewig, S., Menéndez, R., Ferrer, M., Polverino, E., Reyes, S., Gabarrús, A., Marcos, M. A., Cordoba, J., Mensa, J., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.04.009 · Cited by 94 · see citing works
Wadowsky, R. M., Mietzner, S. M., Skoner, D. P., Doyle, W. J., & Fireman, P. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1153-1157.1995 · Cited by 92 · see citing works
Mina, M. J., McCullers, J. A., & Klugman, K. P. (2014) · mBio · doi:10.1128/mbio.01040-13 · Cited by 91 · see citing works
Bartley, J. M., Zhou, X., Kuchel, G. A., Weinstock, G. M., & Haynes, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01164 · Cited by 87 · see citing works
Ruiz, A., Cerdó, T., Jáuregui, R., Pieper, D. H., Marcos, A., Clemente, A., García, F., Margolles, A., Ferrer, M., Campoy, C., et al. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13713 · Cited by 85 · see citing works
Tarabichi, Y., Li, K., Hu, S., Nguyen, C., Wang, X., Elashoff, D., Saira, K., Frank, B., Bihan, M., Ghedin, E., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0133-2 · Cited by 77 · see citing works
Self-citationInterpreting infective microbiota: the importance of an ecological perspective
Rogers, G. B., Hoffman, L. R., Carroll, M. P., & Bruce, K. D. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.03.004 · Cited by 76 · see citing works
Pulmonary antibacterial defenses during mild and severe influenza virus infection
Nickerson, C. L., & Jakab, G. J. (1990) · Infection and Immunity · doi:10.1128/iai.58.9.2809-2814.1990 · Cited by 75 · see citing works
Profiling bacterial community in upper respiratory tracts
Yi, H., Yong, D., Lee, K., Cho, Y.-J., & Chun, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0583-3 · Cited by 75 · see citing works
Inagaki, H., Suzuki, T., Nomoto, K., & Yoshikai, Y. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3280-3287.1996 · Cited by 75 · see citing works
Salk, H. M., Simon, W. L., Lambert, N. D., Kennedy, R. B., Grill, D. E., Kabat, B. F., & Poland, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162803 · Cited by 75 · see citing works
Lu, H., Li, A., Zhang, T., Ren, Z., He, K., Zhang, H., Yang, J., Luo, Q., Zhou, K., Chen, C., et al. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.101 · Cited by 74 · see citing works
Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza
Chaban, B., Albert, A., Links, M. G., Gardy, J., Tang, P., & Hill, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069559 · Cited by 69 · see citing works
Verkaik, N. J., Nguyen, D. T., de Vogel, C. P., Moll, H. A., Verbrugh, H. A., Jaddoe, V. W. V., Hofman, A., van Wamel, W. J. B., van den Hoogen, B. G., Buijs-Offerman, R. M. G. B., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03480.x · Cited by 68 · see citing works
Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro
Franke-Ullmann, G., Pförtner, C., Walter, P., Steinmüller, C., Lohmann-Matthes, M. L., Kobzik, L., & Freihorst, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.268 · Cited by 67 · cited 1× · see citing works
“Prior viral infections dysregulate both alveolar macrophages (64, (131) (132) (133) (134) (135) (136) and neutrophils (65, 128, 129) , thereby inhibiting bactericidal activity.”
BackgroundModulation of potential respiratory pathogens by pH1N1 viral infection.
Leung, R. K.-K., Zhou, J.-W., Guan, W., Li, S.-K., Yang, Z.-F., & Tsui, S. K.-W. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12054 · Cited by 66 · see citing works
Langevin, S., Pichon, M., Smith, E., Morrison, J., Bent, Z., Green, R., Barker, K., Solberg, O., Gillet, Y., Javouhey, E., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000920 · Cited by 64 · see citing works
Nasopharyngeal microbiome diversity changes over time in children with asthma
Pérez-Losada, M., Alamri, L., Crandall, K. A., & Freishtat, R. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170543 · Cited by 63 · see citing works
TANAKA, K. A., Sawamura, S., Satoh, T., Kobayashi, K., & Noda, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5209 · Cited by 62 · see citing works
Pneumonia Complicating Asian Influenza
Oswald, N. C., Shooter, R. A., & Curwen, M. P. (1958) · BMJ · doi:10.1136/bmj.2.5108.1305 · Cited by 62 · see citing works
Reddinger, R. M., Luke-Marshall, N. R., Hakansson, A. P., & Campagnari, A. A. (2016) · mBio · doi:10.1128/mbio.01235-16 · Cited by 62 · see citing works
Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis
Astry, C. L., & Jakab, G. J. (1984) · Journal of Virology · doi:10.1128/jvi.50.2.287-292.1984 · Cited by 58 · see citing works
Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia
Jakab (1982) · PubMed · doi:10.1164/arrd.1982.126.5.778 · Cited by 56 · cited 1× · see citing works
“Prior viral infections dysregulate both alveolar macrophages (64, (131) (132) (133) (134) (135) (136) and neutrophils (65, 128, 129) , thereby inhibiting bactericidal activity.”
Backgroundde Oliveira, M. R., Tafuri, W. L., Afonso, L., de Oliveira, M. A. P., Nicoli, J. R., Vieira, E., SCOTT, P., Melo, M. N., & Vieira, L. Q. (2005) · Parasitology · doi:10.1017/s0031182005008073 · Cited by 55 · see citing works
Kleinerman, E. S., Daniels, C. A., Polisson, R. P., & D, R. S. M. (1976) · PubMed Central · Cited by 53 · see citing works
Changes in microbiota during experimental human Rhinovirus infection
Hofstra, J. J., Matamoros, S., van de Pol, M. A., de Wever, B., Tanck, M. W., Wendt-Knol, H., Deijs, M., van der Hoek, L., Wolthers, K. C., Molenkamp, R., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1081-y · Cited by 50 · see citing works
Karppinen, S., Teräsjärvi, J., Auranen, K., Schuez-Havupalo, L., Siira, L., He, Q., Waris, M., & Peltola, V. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0357oc · Cited by 50 · see citing works
Hirano, T., Kurono, Y., Ichimiya, I., Suzuki, M., & Mogi, G. (1999) · Otolaryngology–Head and Neck Surgery · doi:10.1016/s0194-5998(99)70068-9 · Cited by 47 · see citing works
Tong, H. H., Kosunick, G. M., Fisher, L. M., & DeMaria, T. F. (2000) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940010901106 · Cited by 46 · see citing works
MURPHY, C. P., Fajt, V. R., Scott, H. M., Foster, M., WICKWIRE, P., & McEwen, S. A. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815000722 · Cited by 46 · see citing works
Thors, V., Christensen, H., Morales-Aza, B., Vipond, I., Muir, P., & Finn, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2000oc · Cited by 44 · see citing works
Reddinger, R. M., Luke-Marshall, N. R., Sauberan, S. L., Hakansson, A. P., & Campagnari, A. A. (2018) · mBio · doi:10.1128/mbio.02089-17 · Cited by 39 · see citing works
Wren, J. T., Blevins, L. K., Pang, B., King, L. B., Perez, A. C., Murrah, K. A., Reimche, J. L., Alexander-Miller, M. A., & Swords, W. E. (2014) · Infection and Immunity · doi:10.1128/iai.01856-14 · Cited by 31 · see citing works
Hassoun, A., Huff, M. D., Weisman, D., Chahal, K., Asis, E., Stalons, D., Grigorenko, E., Green, J., Malone, L. L., Clemmons, S., et al. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.04.195 · Cited by 28 · see citing works
Immunobiology of Germfree Mice Infected with Nocardia asteroides
Beaman, B. L., Gershwin, M. E., Scates, S. M., & Ohsugi, Y. (1980) · Infection and Immunity · doi:10.1128/iai.29.2.733-743.1980 · Cited by 22 · see citing works
DE LASTOURS, V., MALOSH, R., RAMADUGU, K., SRINIVASAN, U., DAWID, S., OHMIT, S., & FOXMAN, B. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816001473 · Cited by 20 · see citing works
Takase, H., Nitanai, H., Yamamura, E., & Otani, T. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb01226.x · Cited by 18 · see citing works
Safaeyan, F., Nahaei, M. R., Seifi, S. J., Kafil, H. S., & Sadeghi, J. (2015) · German Medical Science GMS Publishing House · doi:10.3205/dgkh000249 · Cited by 13 · see citing works
Ni, K., Li, S., Xia, Q., Zang, N., Deng, Y., Xie, X., Luo, Z., Luo, Y., Wang, L., Fu, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041104 · Cited by 12 · see citing works
Šplı́chal, I., Rychlı́k, I., Gregorová, D., Šebková, A., Trebichavský, I., Šplı́chalová, A., Muneta, Y., & Mori, Y. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.05.001 · Cited by 6 · see citing works
Kalina (2002) · doi:10.1002/1521-4141(200209)32:9
Gill (2010) · doi:10.1043/1543-2165-134.2.235
Flagged first, then by citations
Cited by
Sorted by citations
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537 · see citing works
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Dashraath, P., Wong, J. L. J., Lim, M. X. K., Lim, L. M., Li, S. W. L., Biswas, A., Choolani, M. A., Mattar, C. N. Z., & Su, L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.021 · Cited by 1,459 · see citing works
Iddir, M., Alex Brito, O., Dingeo, G., Sosa, S., Samouda, H., Frano, M. R. L., & Bohn, T. (2020) · Nutrients · doi:10.3390/nu12061562 · Cited by 795 · see citing works
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513 · see citing works
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 544 · see citing works
The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
Zhang, D., Li, S., Wang, N., Tan, H., Zhang, Z., & Feng, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00301 · Cited by 437 · see citing works
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q. Y., Zhou, M., & Qu, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02752 · Cited by 412 · see citing works
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 384 · see citing works
Sencio, V., Machado, M. G., & Trottein, F. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00361-8 · Cited by 315 · see citing works
Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
Guo, M., Tao, W., Flavell, R. A., & Zhu, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00416-6 · Cited by 305 · see citing works
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Gasmi, A., Noor, S., Tippairote, T., Dadar, M., Menzel, A., & Bjørklund, G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108409 · Cited by 310 · see citing works
Bacterial co‐infections with SARS‐CoV ‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 292 · see citing works
Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., Cerpa, M., Joseph, G., Maki, G., Zervos, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.087 · Cited by 255 · see citing works
Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic
Baud, D., Dimopoulou Agri, V., Gibson, G. R., Reid, G., & Giannoni, E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00186 · Cited by 240 · see citing works
Microbiota Modulation of the Gut-Lung Axis in COVID-19
de Oliveira, G. L. V., Oliveira, C. N. S., Pinzan, C. F., de Salis, L. V. V., & Cardoso, C. R. D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635471 · Cited by 238 · see citing works
Melatonin: Roles in influenza, Covid‐19, and other viral infections
Anderson, G., & Reiter, R. J. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2109 · Cited by 212 · see citing works
Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence
Groves, H., Higham, S. L., Moffatt, M. F., Cox, M. J., & Tregoning, J. S. (2020) · mBio · doi:10.1128/mbio.03236-19 · Cited by 213 · see citing works
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
Bao, L., Zhang, C., Dong, J., Zhao, L., Li, Y., & Sun, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01840 · Cited by 207 · see citing works
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Al-Kuraishy, H. M., Al-Gareeb, A. I., Al-Hussaniy, H. A., Al-Harcan, N. A. H., Alexiou, A. T., & Batiha, G. E. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108516 · Cited by 195 · see citing works
Sun, Z., Song, Z., Liu, C., Tan, S., Lin, S., Zhu, J., Dai, F., Gao, J., She, J.-L., Mei, Z., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02212-0 · Cited by 170 · see citing works
Tang, L., Gu, S., Gong, Y., Li, B., Lu, H., Li, Q., Zhang, R., Gao, X., Wu, Z., Zhang, J., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.05.013 · Cited by 166 · see citing works
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results
Caruana, G., Croxatto, A., Coste, A. T., Opota, O., Lamoth, F., Jaton, K., & Greub, G. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.019 · Cited by 158 · see citing works
Gut-lung axis and dysbiosis in COVID-19
Aktaş, B., & Aslım, B. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-102 · Cited by 158 · see citing works
The human microbiome and COVID-19: A systematic review
Yamamoto, S., Saito, M., Tamura, A., Prawisuda, D., Mizutani, T., & Yotsuyanagi, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253293 · Cited by 146 · see citing works
Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases
Saint‐Criq, V., Lugo‐Villarino, G., & Thomas, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101235 · Cited by 143 · see citing works
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Ahlawat, S., Asha, A., & Sharma, K. K. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198103 · Cited by 131 · see citing works
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
He, L., Ren, L., Li, J., Wu, Y.-N., Li, X., & Zhang, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01388 · Cited by 134 · see citing works
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Peng, X., Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Zhu, B., & Routy, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596631 · Cited by 122 · see citing works
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Maio, F. D., Posteraro, B., Ponziani, F. R., Cattani, P., Gasbarrini, A., & Sanguinetti, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00131-7 · Cited by 115 · see citing works
Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement
He, X., Zhao, S., & Li, Y. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/6666114 · Cited by 117 · see citing works
Assefa, M. (2022) · Pneumonia · doi:10.1186/s41479-022-00096-z · Cited by 115 · see citing works
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons
Oliva, J., & Terrier, O. (2021) · Viruses · doi:10.3390/v13091725 · Cited by 85 · see citing works
Inhalable MOF‐Derived Nanoparticles for Sonodynamic Therapy of Bacterial Pneumonia
Pan, X., Wu, N., Tian, S., Guo, J., Wang, C., Sun, Y., Huang, Z., Chen, F., Wu, Q., Jing, Y., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112145 · Cited by 104 · see citing works
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
Khatiwada, S., & Subedi, A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100073 · Cited by 103 · see citing works
Potempa, L. A., Rajab, I. M., Hart, P. C., Bordón, J., & Fernandez-Botrán, R. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0473 · Cited by 102 · see citing works
Yang, A., Chen, C., Hu, Y., Zheng, G., Chen, P., Xie, Z., Fan, H., Sun, Y., Wu, P., Jiang, W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01488-22 · Cited by 101 · see citing works
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
Shahbazi, R., Yasavoli‐Sharahi, H., Alsadi, N., Ismail, N., & Matar, C. (2020) · Molecules · doi:10.3390/molecules25214891 · Cited by 101 · see citing works
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19
Ren, L., Wang, Y., Zhong, J., Li, X., Xiao, Y., Li, J., Yang, J., Fan, G., Guo, L., Shen, Z., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0814oc · Cited by 100 · see citing works
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Sirivongrangson, P., Kulvichit, W., Payungporn, S., Pisitkun, T., Chindamporn, A., Peerapornratana, S., Pisitkun, P., Chitcharoen, S., Sawaswong, V., Worasilchai, N., et al. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00362-8 · Cited by 98 · see citing works
Manohar, P., Loh, B., Athira, S., Nachimuthu, R., Hua, X., Welburn, S. C., & Leptihn, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01434 · Cited by 95 · see citing works
Horn, K. J., Schopper, M. A., Drigot, Z., & Clark, S. E. (2022) · Nature Communications · doi:10.1038/s41467-022-31074-0 · Cited by 95 · see citing works
Zhang, H., Ai, J., Yang, W., Zhou, X., He, F., Xie, S., Zeng, W., Li, Y., Yu, Y., Gou, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa663 · Cited by 94 · see citing works
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Fakharian, F., Thirugnanam, S., Welsh, D. A., Kim, W., Rappaport, J., Bittinger, K. L., & Rout, N. (2023) · Microorganisms · doi:10.3390/microorganisms11071849 · Cited by 93 · see citing works
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Kamel, M. S., Aleya, S., Alsubih, M., & Aleya, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020217 · Cited by 96 · see citing works
The impact of lung microbiota dysbiosis on inflammation
Yang, D., Xing, Y., Song, X., & Qian, Y. (2019) · Immunology · doi:10.1111/imm.13139 · Cited by 92 · see citing works
Qu, J., Cai, Z., Liu, Y., Duan, X., Han, S., Liu, J., Zhu, Y., Jiang, Z., Zhang, Y., Zhuo, C., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.641920 · Cited by 87 · see citing works
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects
Kurian, S. J., Unnikrishnan, M. K., Miraj, S. S., Bagchi, D., Banerjee, M., Reddy, B. S., Rodrigues, G. S., Manu, M. K., Saravu, K., Mukhopadhyay, C., et al. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.03.002 · Cited by 87 · see citing works
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 82 · see citing works
Hypoxia: The “Invisible Pusher” of Gut Microbiota
Han, N., Pan, Z., Liu, G., Yang, R., & Bi, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.690600 · Cited by 79 · see citing works
Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease
Zhou, A., Lei, Y., Tang, L., Hu, S., Yang, M., Wu, L., Yang, S., & Tang, B. (2020) · Journal of Bacteriology · doi:10.1128/jb.00454-20 · Cited by 78 · see citing works
Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential
Hussain, I., Cher, G. L. Y., Abid, M. A., & Abid, M. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765965 · Cited by 72 · see citing works
Breath analysis for detection of viral infection, the current position of the field
Gould, O., Ratcliffe, N. A., Król, E., & Costello, B. D. L. (2020) · Journal of Breath Research · doi:10.1088/1752-7163/ab9c32 · Cited by 72 · see citing works
Gao, M., Wang, H., Luo, H., Sun, Y., Wang, L., Ding, S., Ren, H., Gang, J., Rao, B., Liu, S., et al. (2021) · Advanced Science · doi:10.1002/advs.202102785 · Cited by 71 · see citing works
Liu, F., Ye, S., Zhu, X. J., He, X., Wang, S., Li, Y., Lin, J., Wang, J., Lin, Y., Ren, X., et al. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02583-7 · Cited by 70 · see citing works
The find of COVID-19 vaccine: Challenges and opportunities
ElBagoury, M., Tolba, M. M., Nasser, H. A., Jabbar, A., Elagouz, A. M., Aktham, Y., & Hutchinson, A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.12.025 · Cited by 70 · see citing works
PASCALE, G. D., Maio, F. D., Carelli, S., Angelis, G. D., Cacaci, M., Montini, L. M., Bello, G., Cutuli, S. L., Pintaudi, G., Tanzarella, E. S., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03623-4 · Cited by 68 · see citing works
Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19
Walton, G., Gibson, G. R., & Hunter, K. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003980 · Cited by 66 · see citing works
Vignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 64 · see citing works
Gupta, A., Karyakarte, R. P., Joshi, S., Das, R., Jani, K., Shouche, Y. S., & Sharma, A. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104880 · Cited by 65 · see citing works
Aguilera, E. R., & Lenz, L. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00105 · Cited by 65 · see citing works
Next-Generation Sequencing Reveals the Progression of COVID-19
Chen, X., Kang, Y., Luo, J., Pang, K., Xu, X. Y., Wu, J., Li, X., & Jin, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.632490 · Cited by 66 · see citing works
Activation of TLR4 by viral glycoproteins: A double-edged sword?
Halajian, E. A., LeBlanc, E. V., Gee, K., & Colpitts, C. C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1007081 · Cited by 63 · see citing works
Microbiota and COVID-19: Long-term and complex influencing factors
Gang, J., Wang, H., Xue, X., & Zhang, S. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.963488 · Cited by 61 · see citing works
Shinde, T., Hansbro, P. M., Sohal, S. S., Dingle, P., Eri, R., & Stanley, R. (2020) · Microorganisms · doi:10.3390/microorganisms8060921 · Cited by 61 · see citing works
Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota
Kaneko, K., Akagawa, S., Akagawa, Y., Kimata, T., & Tsuji, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01616 · Cited by 61 · see citing works
Mullish, B. H., Marchesi, J. R., McDonald, J. A. K., Pass, D. A., Masetti, G., Michael, D. R., Plummer, S. F., Jack, A. A., Davies, T. S., Hughes, T. R., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1900997 · Cited by 59 · see citing works
At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A
Otero, A. M., & Antonson, A. M. (2022) · Immunological Reviews · doi:10.1111/imr.13125 · Cited by 55 · see citing works
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
Favilli, A., Gentili, M. M., Raspa, F., Giardina, I., Parazzini, F., Vitagliano, A., Borisova, A. V., & Gerli, S. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1774875 · Cited by 57 · see citing works
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Romani, L., CHIERICO, F. D., Macari, G., Pane, S., Ristori, M. V., Guarrasi, V., Gardini, S., Pascucci, G. R., Cotugno, N., Perno, C. F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.908492 · Cited by 60 · see citing works
Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia
Alqahtani, A., Alamer, E., Mir, M. A., Alasmari, A., Alshahrani, M. M., Asiri, M., Ahmad, I. S., Alhazmi, A., & Algaissi, A. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042424 · Cited by 56 · see citing works
Shi, T., Wang, J., Dong, J., Hu, P., & Guo, Q. (2023) · Pathogens · doi:10.3390/pathogens12091110 · Cited by 55 · see citing works
Next-Generation Probiotics and Their Metabolites in COVID-19
Gautier, T., Gall‐David, S. L., Sweidan, A., Tamanai‐Shacoori, Z., Jolivet‐Gougeon, A., Loréal, O., & Bousarghin, L. (2021) · Microorganisms · doi:10.3390/microorganisms9050941 · Cited by 54 · see citing works
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID‐19 Patients
Soltani, S., Zakeri, A., Zandi, M., Kesheh, M. M., Tabibzadeh, A., Dastranj, M., Faramarzi, S., Didehdar, M., Hafezi, H., Hosseini, P., et al. (2021) · BioMed Research International · doi:10.1155/2021/6670798 · Cited by 52 · see citing works
Mucus, Microbiomes and Pulmonary Disease
Meldrum, O. W., & Chotirmall, S. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060675 · Cited by 53 · see citing works
Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study
Slob, E. M. A., Brew, B. K., Vijverberg, S. J. H., Kats, C. J. A. R., Longo, C., Pijnenburg, M. W. H., van Beijsterveldt, T. C. E. M., Dolan, C. V., Bartels, M., Magnusson, P., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02021-2019 · Cited by 53 · see citing works
Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
Almeida, C., Oliveira, R., Baylina, P., Fernandes, R., Teixeira, F. G., & Barata, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112742 · Cited by 52 · see citing works
Hafiz, T. A., Alghamdi, S. S., Mubaraki, M. A., Alghamdi, S. S. M., Alothaybi, A., Aldawood, E., & Alotaibi, F. E. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.01.004 · Cited by 51 · see citing works
Sputum microbiome profiling in COPD: beyond singular pathogen detection
Ditz, B., Christenson, S. A., Rossen, J. W. A., Brightling, C. E., Kerstjens, H. A. M., van den Berge, M., & Faiz, A. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214168 · Cited by 52 · see citing works
Gut microbiome a promising target for management of respiratory diseases
Trivedi, R., & Barve, K. H. (2020) · Biochemical Journal · doi:10.1042/bcj20200426 · Cited by 51 · see citing works
Clinical Implications of Polymicrobial Synergism Effects on Antimicrobial Susceptibility
Little, W., Black, C., & Smith, A. C. (2021) · Pathogens · doi:10.3390/pathogens10020144 · Cited by 49 · see citing works
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
Cyprian, F. S., Sohail, M. U., Abdelhafez, I., Salman, S., Attique, Z., Kamareddine, L., & Al‐Asmakh, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.071 · Cited by 50 · see citing works
Cross-talk between immune system and microbiota in COVID-19
Ghavami, S. B., Pourhamzeh, M., Farmani, M., Raftar, S. K. A., Shahrokh, S., Shpichka, A. I., Aghdaei, H. A., Hakemi-Vala, M., Hossein‐Khannazer, N., Timashev, P. S., et al. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1991311 · Cited by 49 · see citing works
Shi, H. Y., Zhu, X., Li, W. L., Mak, J. W. Y., Wong, S. H., Zhu, S. T., Guo, S. L., Chan, F. K. L., Zhang, S. T., & Ng, S. C. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02519-x · Cited by 48 · see citing works
The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury
Zinter, M. S., Lindemans, C. A., Versluys, B. A. B., Mayday, M. Y., Sunshine, S., Reyes, G. A., Sirota, M., Sapru, A., Matthay, M. A., Kharbanda, S., et al. (2020) · Blood · doi:10.1182/blood.2020009246 · Cited by 48 · see citing works
Mohammed, A. K., Alghetaa, H., Miranda, K., Wilson, K. M., Singh, N. P., Cai, G., Putluri, N., Nagarkatti, P. S., & Nagarkatti, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176244 · Cited by 48 · see citing works
Krämer, A., Lexow, F., Bludau, A., Köster, A. M., Misailovski, M., Seifert, U., Eggers, M., Rutala, W. A., Dancer, S. J., & Scheithauer, S. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00186-23 · Cited by 47 · see citing works
Prasad, N., Rhodes, J., Deng, L., McCarthy, N. L., Moline, H. L., Baggs, J. M., Reddy, S. C., Jernigan, J. A., Havers, F. P., Sosin, D. M., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad028 · Cited by 46 · see citing works
Bacterial infections in patients hospitalized with COVID-19
Moreno‐Torres, V., de Mendoza, C., de la Fuente, S., Sánchez, E., Martínez‐Urbistondo, M., Herráiz, J., Gutiérrez, A., Gutiérrez, Á., Hernández, C., Callejas, A., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02824-7 · Cited by 49 · see citing works
Ferreira, C., Viana, S., & Reis, F. (2020) · Microorganisms · doi:10.3390/microorganisms9010053 · Cited by 45 · see citing works
The role of mucosal barriers in disease progression and transmission
Bustos, N. A., Ribbeck, K., & Wagner, C. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115008 · Cited by 46 · see citing works
Woehlk, C., von Bülow, A., Ghanizada, M., Soendergaard, M. B., Hansen, S., & Porsbjerg, C. M. (2022) · European Respiratory Journal · doi:10.1183/13993003.00446-2022 · Cited by 44 · see citing works
Little, J. S., Tandon, M., Hong, J., Nadeem, O., Sperling, A. S., Raje, N. S., Munshi, N. C., Frigault, M. J., Barmettler, S., & Hammond, S. P. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010524 · Cited by 44 · see citing works
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
Varricchi, G., Poto, R., Ianiro, G., Punziano, A., Marone, G., Gasbarrini, A., & Spadaro, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712915 · Cited by 44 · see citing works
Gao, J., Yan, Y., Gao, S., Li, H., Li, H., Cheng, J., Hu, Y., Cai, K., Zhang, X., & Li, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.11.009 · Cited by 43 · see citing works
Patra, S., Saxena, S., Sahu, N., Pradhan, B., & Roychowdhury, A. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09748-w · Cited by 43 · see citing works
Hoang, V. T., Dao, T.-L., Ly, T. D. A., Belhouchat, K., Chaht, K. L., Gaudart, J., Mrenda, B. M., Drali, T., Yezli, S., Alotaibi, B., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1693247 · Cited by 42 · see citing works
The Interplay between the Host Microbiome and Pathogenic Viral Infections
González, R., & Elena, S. F. (2021) · mBio · doi:10.1128/mbio.02496-21 · Cited by 42 · see citing works
Smart responsive materials for antibacterial therapy: Progress, opportunities, and challenges
Fu, J., Wang, C., Liu, X., Zhu, S., Zheng, Y., Li, Z., Cui, Z., Zhang, Y., Jiang, H., Cao, Y., et al. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101532 · Cited by 42 · see citing works
Lan, X.-F., Olaleye, O. E., Lu, J.-L., Yang, W., Du, F., Yang, J., Cheng, C., Shi, Y.-H., Wang, F., Zeng, X.-S., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00651-2 · Cited by 41 · see citing works
The internationalization of human microbiome research
Porras, A. M., & Brito, I. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.09.012 · Cited by 39 · see citing works
- Authors
- Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Deng, Jane C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-16
- Volume
- 9
- Pages
- 2640-2640
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC6250824
- OpenAlex
- W2900850632
- Semantic Scholar
- 8c97d3d01a4d77e5f4f458ed46ba5399f3647a74
- Cited by
- 495
- References
- 147
- Citations by year
- 2026: 29 · 2025: 53 · 2024: 58 · 2023: 77 · 2022: 89 · 2021: 110 · 2020: 72 · 2019: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL108949)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- respiratory viral infections, influenza, secondary bacterial pneumonia, airway microbiome, dysbiosis, gut microbiota, mucosal microbiota, host defense, viral-bacterial interactions, antiviral immunity
- MeSH terms
- Gastrointestinal Microbiome, Host Microbial Interactions, Humans, Immunity, Innate, Respiratory Tract Infections, Virus Diseases, Pneumonia, Bacterial, Coinfection, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review